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Multiple Sclerosis (MS) is a chronic degenerative autoimmune disease of the 
central nervous system that affects approximately 2.1 million people world-wide 
(National Multiple Sclerosis Society, 2005). Symptoms include limitations with both 
physical (coordination, muscle weakness, vision problems, etc.) and cognitive 
functioning and vary by individual. There is currently no cure for MS and treatment is 
based around symptom management (Coyle & Hamaad, 2006). One means for symptom 
management is physical activity (PA). PA has been shown to effectively aid symptom 
management by reducing the number, length, and duration of disease flare-ups (Motl, 
McAuley, & Snook, 2005), as well as increasing overall quality of life (Stuifbergen, 
Blozis, Harrison, & Becker, 2006). In spite of this evidence, the MS population is one of 
the most inactive segments of the population, even among patients with chronic diseases 
(Motl & Snook, 2008). Understanding what motivates this population to be physically 
active is the first step in developing an effective, sustainable, PA intervention for disease 
management. Using Path Analysis, this study examined potential predictors of motivation 
for PA in individuals with MS (n = 215) finding self-determined motivation, in 
conjunction with self-efficacy, as predictors of PA participation, and self-efficacy and PA 
participation as a predictors of quality of life. In the model, self-efficacy and identified 
regulation predicted PA participation, and PA participation predicted quality of life, χ2(1) 
= .02, p = .867; RMSEA = .00; CFI = 1.0; SRMR = .002. Open-ended responses from 
participants supported the model, indicating that self-efficacy and identified regulation 
were predictors of PA, and PA was a predictor of increased overall quality of life. The 
findings and resulting model may be used to guide future interventions to promote PA 
participation in individuals with MS and consequently enhance long-term quality of life.    
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CHAPTER I 
INTRODUCTION 
 
 
 Multiple Sclerosis (MS) affects approximately 2.1 million otherwise-healthy 
people world-wide. It is a chronic degenerative autoimmune disease of the central 
nervous system for which there is no known cure and the only course of action is disease 
management in the form of slowing progression and controlling symptoms (National 
Multiple Sclerosis Society, 2005). Individuals are usually diagnosed in their late teens to 
early 20’s and rarely have a reduced life expectancy, making it a disease that people live 
with for a lifetime (Iezzoni, 2010). Symptoms of MS can include (but are not limited to) 
muscle weakness, loss of coordination, cognitive impairments, vision problems, bowel 
and bladder control problems, and anything else that is neurologically based, meaning the 
list of symptoms is extremely vast and varies by individual (Coyle & Hamaad, 2006). 
These symptoms can drastically reduce quality of life for the patient. In order to increase 
overall quality of life long-term for the individual, it becomes imperative that all possible 
steps are taken to slow disease progression and control symptoms. Methods for disease 
management primarily include drug therapy, however increasingly, patients are turning to 
other lifestyle modifications to aid in overall disease control. One of these modifications 
that has been extremely successful is the incorporation of regular physical activity.  
 Physical activity (PA) has been shown to be an effective means to aid in MS 
symptom management for many patients (Motl, McAuley, & Snook, 2005; Motl & 
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Pilutti, 2012). This symptom management is seen in physical and cognitive symptoms, 
and appears to aid in the reduction of the length and duration of disease flare-ups (Snook 
& Motl, 2009; Stuifbergen et al., 2006). For this reason, PA appears to be a viable 
intervention for many individuals with MS to aid in long-term disease management. 
Integrating PA into the lives of people upon initial diagnosis (if they are not already 
active), before symptoms progress to a point where PA is physically impossible, seems to 
be a way to aid in disease management with a simple lifestyle change. Recent 
recommended activity levels for individuals with MS to see benefits are relatively low 
and should be achievable for most individuals (Latimer-Cheung et al., 2013). In spite of 
this growing body of evidence, the MS population as a whole is very inactive (Motl & 
Snook, 2008; Petajan et al., 1996). This presents a complex problem; one of the very 
things that could aid in symptom control is often absent from the lives of these 
individuals.  
In addition to the physical benefits that MS patients see from PA participation, 
there also appear to be benefits to overall quality of life (Motl & Snook, 2008; Motl & 
Gosney, 2008; Petajan et al., 1996; Stuifbergen et al., 2006; Sutherland, Andersen, & 
Stoové, 2001). This makes sense in light of what disease symptom control can represent 
to an individual. Controlling or slowing the progression of the aforementioned symptoms, 
even if just partially, could have a huge impact on how patients experience their lives. 
For instance, controlling symptoms a small amount could mean the difference between 
being sedentary and being mobile enough to get around one’s home unaided, walk up and 
down stairs, or be able to drive a car.  These enhanced abilities translate into improved 
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quality of life. For this reason, there is a direct link between symptoms and reported 
quality of life (Motl & Gosney, 2008).  
 Previous research on motives for PA in individuals with MS has followed Social 
Cognitive Theory (SCT) (Motl & Snook, 2008; Young, Plotnikoff, Collins, Callister, & 
Morgan, 2014). Briefly, SCT is a cognitive behavioral theory based on the individual’s 
self-efficacy for behavior and their outcome expectancies for those behaviors. It focuses 
on the relationship between the person, their behavior, and the environment, and it states 
that behavior is a result of the combination of the integrative influences of the 
environment, experiences, and expected results (Bandura, 2004).  SCT relies heavily on 
the concept of self-efficacy, and one’s belief in the ability to accomplish a behavior, as 
the underlying explanation for behavior. The more self-efficacy an individual exhibits for 
a behavior, the more likely the individual is going to develop the behavior into a long-
term activity. 
The current project uses Self-Determination Theory (SDT), as well as self-
efficacy, to examine the motivational aspects of PA participation in individuals with MS. 
Similar to SCT, SDT is based in the general cognitive behavioral framework. SDT relies 
on the basic needs of competency, autonomy, and relatedness as the driving constructs 
for behavior motivation and focuses on the origination of needs in the individual (Deci & 
Ryan, 1985, 2004). According to SDT, the more autonomously controlled the motivation 
is for a behavior, the more internalized the behavior becomes, and the more likely the 
behavior will continue. This resulting concept is self-determination (Deci & Flaste, 
1996). Unlike SCT, which relies on quantity of motivation to predict behavior (amount of 
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self-efficacy), SDT also examines the origination of the motivation (the internalization of 
behavior as self-determination). In this way, SDT provides a framework that examines 
motivation in a detailed manner in order to predict participation.  
There is support for using SDT and SCT in tandem to gain a better understanding 
of PA motivation. Self-efficacy has been shown to be related to the construct of 
perceived competence in SDT (Sweet, Fortier, Strachan, & Blanchard, 2012). By using 
self-efficacy to indicate the amount of motivation for PA, and SDT to indicate how self-
determined the motivation is, a more complete picture of PA motivation emerges (Sweet 
et al., 2012). When specifically considering the MS population, the combination of self-
efficacy and SDT may provide a clearer roadmap to increased PA participation, and 
consequently increased overall quality of life, as has been seen in other populations 
(Sweet et al., 2012). This deeper understanding of motivation is the goal of this project in 
order to eventually integrate this knowledge into future PA protocols for people with MS.  
Additional evidence supporting the use of SDT and SCT comes from a 2014 case 
study examined a single individual with MS who was highly physically active as a 
competitive elite amateur mountain bike racer (Fasczewski, Gill, & Barrett, 2015).  The 
results of the case study suggested that the motives for PA were linked to the 
participant’s perceived ability to control her disease and that PA participation increased 
her overall quality of life. The participant reported living what she perceived to be a 
normal, healthy, active life, which she attributed to her continued PA participation. The 
underlying themes supported the theoretical approach of SDT and self-efficacy. This 
participant did struggle with many of the same issues seen in most MS patients (physical 
 
 
 
5 
 
 
challenges, depression) but she spoke of using these challenges as personal motivators to 
remain active.  This research gives insight into one person with MS’s perspective and 
approach to PA participation.  
Following the aforementioned case study, the next logical step in this examination 
of motivational factors for PA participation was to expand to a group of highly physically 
active individuals with MS. Using SDT as a framework, pilot data were collected via 
surveys from 15 highly active individuals with MS. Additionally, semi-structured 
interviews were performed with 9 of these participants in order to add depth and context 
to the results of the survey data. The interviews focused on a) motivation and strategies 
used to maintain PA, and b) the benefits and impact of PA in their lives. Results indicated 
that participants were highly motivated, and the main themes were in line with SDT; 
participants described feelings of accomplishment and competence in both their PA and 
daily life, as well as a sense of independence and autonomy.  Similarly, all participants 
cited benefits from PA that included enhanced satisfaction with life and an overall 
positive outlook on life. These results support the development of the current project that 
seeks to look at PA motivation and quality of life outcomes in the larger MS population. 
The current study examines motivation for PA in individuals with MS using self-
determined motivation, as defined by SDT, in conjunction with self-efficacy as predictors 
of PA participation. This project also examines the relationship between PA participation 
and quality of life. The goal of this investigation is to develop a model that can be used to 
understand and guide interventions to promote PA participation in individuals with MS 
and consequently enhance long-term quality of life. Before any effective PA intervention 
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protocol for the MS population can be designed using SDT (or any other theory) it is 
imperative that we understand the motivation for, and benefits of, PA in this population. 
This research takes a modeling approach with the aim of clarifying those relationships.  
Purpose 
 The aim of this research is to model the relationships among self-determined 
motivation, PA, and quality of life in individuals with MS. The overall proposed model 
(depicted in Figure 1) combines the two main research questions.  The first part of the 
model, and research question 1, focus on the relationship of self-determined motivation 
and self-efficacy to PA. The second part of the model, and research question 2, focus on 
the relationship of physical activity to quality of life. Based on the existing literature with 
other populations, self-determined motivation impacts PA participation and PA predicts 
quality of life. A third research question will explore the question of model equivalency 
when it is divided by physical disability level to see if the model holds across disability 
level of the individual.  
 
 
Figure 1. Proposed Overall Model of the Relationship Between Self-Determined 
Motivation, PA, and Quality Of Life. 
 
 
Quality of Life/Life 
Satisfaction 
Physical Activity
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Research Question 1 
Are self-determined motivation and self-efficacy for PA related to PA levels 
in people with MS?  In accordance with SDT, individuals who are highly self-
determined for a behavior exhibit high levels of the behavior (Deci & Ryan, 2004). 
Although SDT is the primary motivational framework for this research, self-efficacy will 
also be used as a predictor for PA. Past research with the MS population using SCT has 
suggested that self-efficacy is a key predictor of PA participation.  Self-efficacy is related 
to the concept of perceived competence in SDT but remains a unique construct, lending 
support for a combined SDT/self-efficacy model (Sweet et al., 2012). Consequently, 
adding self-efficacy to self-determined motivation in this model may provide a more 
complete picture of motivation for PA.  
Hypothesis 1a: Self-determined motivation for PA is linearly related to PA 
participation in individuals with MS.  
Hypothesis 1b: Self-efficacy for PA is linearly related to PA participation in 
individuals with MS.  
Research Question 2 
Is PA participation related to quality of life? It is expected that individuals with 
MS who are more physically active have higher perceived quality of life. In this research, 
quality of life is examined as overall life satisfaction (Diener, Emmons, Larsen, & 
Griffin, 1985) and also as a multi-dimensional construct including social, spiritual, 
emotional, cognitive, physical, and functional/activities of daily living (ADL), as well as 
integrated quality of life  (Gill et al., 2011). It is expected that PA participation will be 
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related to overall life satisfaction and integrated quality of life; PA is also expected to 
relate to several dimensions of quality of life, with its strongest relationships to physical, 
functional (ADL), and emotional quality of life.  
Hypothesis 2a: PA participation is positively related to life satisfaction and 
integrated quality of life.  
Hypothesis 2b: PA participation is positively related to the individual quality of 
life dimensions (physical, functional/ADL), emotional, social, spiritual, 
cognitive).  
 Once research questions 1 and 2 were answered, they were combined to examine 
the relationships as a complete model. This model gives an accurate picture of the 
relationship between self-efficacy for PA, self-determined motivation for PA, PA 
participation, and quality of life. This overall model was used for research question 3. 
Research Question 3  
Does disease step (level of disability) change the relationships among 
motivation, PA, and quality of life? This exploratory question has two parts. First, is 
disability level related to PA participation, motivation or quality of life?  Second, does 
the overall model of motivation, PA participation, and quality of life hold constant for 
different disability levels; that is, are the models of the relationships equivalent across 
disability level groups? Previous research has found that the more disabled the individual 
is, the less likely it is that they participate in PA (Beckerman, de Groot, Scholten, 
Kempen, & Lankhorst, 2010). For this reason, disability level needs to be considered 
when examining motives for PA participation. Disability level will be assessed using the 
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Patient Determined Disease Step (PDDS) measure which gives a single score that 
determines the level of disease symptoms the patients is living with.  
Hypothesis 3a: Disability/higher disease step will be linearly related to self-
determined motivation for PA and PA participation.   
Exploratory research question: Does the motivation/PA/QoL model hold across 
disability levels?  
Proposed Model 
 In combination, the first two research questions create the overall proposed model 
shown in figure 1. This model should lend insight into the level of self-determined 
motivation for PA individuals with MS exhibit, the role that self-efficacy plays in this 
relationship, as well as the overall impact that PA has on quality of life/satisfaction with 
life for this population. The third research question will then add understanding to the PA 
behavior of the MS population as related to disability status by examining this model 
across different disability levels. Gaining an understanding of the relationships in this 
model will allow future development of PA interventions that are rooted in a strong 
theoretical base.
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CHAPTER II 
LITERATURE REVIEW 
 
 This chapter will briefly examine the foundational literature used as rationale for 
this project. It begins with an examination of the basic physiology of MS, including 
treatment options, PA recommendations, and impact of PA on overall disease 
progression. There is then a discussion on current findings on the relationship between 
PA and quality of life in MS patients. Following that is an examination of the theories of 
behavior change relevant to this project, specifically focusing on Social Cognitive 
Theory, which has been used in previous research examining PA in MS patients; and 
Self-Determination Theory, which is the theoretical background for the current research.   
What is MS? 
Multiple Sclerosis is a chronic degenerative neurological disease that attacks the 
central nervous system (CNS) (National Multiple Sclerosis Society, 2005). It progresses 
at varying rates depending on the individual and type of MS. Once symptoms appear 
there is always progression. MS can affect any area of the nervous system; for this reason 
symptoms are variable and are not exhibited in exactly the same way for any two 
individuals (Coyle & Hamaad, 2006; Iezzoni, 2010). Because of these variations among 
patients, MS is a very complicated disease to diagnose and treat. Treatment usually 
involves multiple methods, which can include both drug therapies and more recently, PA. 
Current estimates put the number of people in the United States living with MS at 
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between 250,000 and 400,000 and there is no known cure (Iezzoni, 2010; “What is 
MS?,2012). MS is typically diagnosed when patients are in their late teens to late 20s, 
although it can be diagnosed in patients as late as 60 years old (Coyle & Hamaad, 2006). 
Most patients are otherwise healthy.  
Basic Physiology of MS 
The role of the Central Nervous System. Understanding MS begins with a basic 
understanding of the Central Nervous System (CNS), its functions, and how MS limits 
these functions as the disease progresses (Iezzoni, 2010). The CNS is comprised of the 
brain and spinal cord and is the command center for all movement in the body, both 
voluntary (e.g. conscious muscle movement) and involuntary (e.g., unconscious organ 
functions), as well as all brain activity (e.g., learning, language, thought) (Talley, 2008). 
The job of the CNS is rapid communication and this is done using electrical and chemical 
signals. Cells within the CNS take two forms, nerve cells (neurons) and glia cells 
(neuroglia) (Brodal, 2010). Neurons are specialized cells that conduct and receive signals 
that dictate movement through the body. Neuroglia are supportive cells that exist in 
various forms and aid in the transmission of signals as well assess damage and perform 
reparative functions through the nervous system (Brodal, 2010). Communication in the 
nervous system originates in the brain and signals are sent from one neuron to the next 
until they arrive at the end location.  
Neurons are comprised of a cell body and cytoplasm with two different types of 
extensions, dendrites and axons (Brodal, 2010). Most CNS neurons have several 
dendrites, which are short and branching and receive signals from other neurons. Some 
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neurons have dendrites that both send and receive signals (Brodal, 2010). Neurons with 
axons have only one axon and its purpose is to transmit signals (Brodal, 2010; Iezzoni, 
2010). Axons vary in length depending on the type and location of the muscle that they 
are signaling. Axons terminate at a synapse where a signal is transmitted to the receiving 
cell telling it what action to execute or to inhibit (Brodal, 2010). The signal is transmitted 
using an electrical gradient which passes it along the outer membrane of the axon. To 
enhance the speed of transmission, a specific type of neuroglia called oligodendrocytes 
form a covering over the axon, which is called the myelin (Brodal, 2010; Iezzoni, 2010).  
Numerous oligodendrocytes attach to each axon with small gaps in between each 
oligodendrocyte, and this myelin increases the speed of the signal transmission (figure 2) 
(Iezzoni, 2010). The entire process of signal transmission appears almost instantaneous. 
 
 
Figure 2. Basic Anatomy of a Neuron (Iezzoni, 2010).  
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 MS in an inflammatory disease that is characterized by damage to the myelin 
covering, and consequently the underlying nerve cell fibers, leading to slowed or blocked 
transmission of signals (figure 3). This demyelination of the CNS results in limited 
functioning both physically and cognitively (Ji & Goverman, 2008; National Library of 
Medicine (U.S.), 2000). The reasons for this damage are still under debate, but most MS 
researchers believe that MS is an autoimmune disorder, meaning that the immune system 
malfunctions and attacks cells within the body instead of the foreign cells it is supposed 
to attack (Kaldor, 2013). The damage to the myelin and axon causes the transmission of 
the signal to be slowed; the most common symptoms include the loss of coordination, 
reduced cognitive ability, loss of muscle control, tingling sensation, loss of sensation, loss 
of sight as well as numerous other neurologic impairments (Boggs, 2008). The neuroglia 
that are specific to the repair of neurons attempt to fix this damage and the result is scar 
tissue (called lesions) that allow the neuron to continue functioning but at a reduced 
capacity (Boggs, 2008). Most commonly, individuals with MS have periods of symptom 
flare-up when this damage is occurring and then periods of more normal functioning, 
where the resulting scar tissue has formed and normal functioning has returned, albeit 
somewhat limited (Halper & Holland, 1996). Over time these lesions become more 
numerous and physical and cognitive functioning is increasingly reduced (Kalb, 1996; 
Kaldor, 2013). The lesions are what is seen in Magnetic Resonance Imaging (MRI) when 
an individual is initially diagnosed with MS and also what is examined when disease 
progression is measured (Fleming, 2002; Iezzoni, 2010). Depending on where these 
lesions are in the brain or spinal cord will determine the symptoms that a patient exhibits. 
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No two lesions are the same and no two individuals have the same number or type of 
lesions, which is why MS presents differently in each individual (Boggs, 2008; Fleming, 
2002; Iezzoni, 2010). Lesions are typically found on the white matter in the nervous 
system, often near blood vessels (American College of Sports Medicine, 2002; Kaldor, 
2013). The reason for this is not understood, but it is the basis for some of the newer 
experimental MS treatments that focus more on blood vessel involvement and less on 
neurological damage (Kaldor, 2013). So far the results from this research is mixed and 
the treatments are not considered an effective means of treatment (Kaldor, 2013). 
 
 
Figure 3. An Illustration of a Normal Neuron with Healthy Functioning Myelin and a 
Neuron with Damaged Myelin from MS (Iezzoni, 2010). 
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Diagnosis of MS. Diagnosis of MS can be as varied as the disease itself. It may 
be challenging to diagnose because the disease presents differently in each case and many 
symptoms mimic other diseases. It is not uncommon for a patient to be diagnosed 
initially with a different neurological condition prior to the MS diagnosis (Kalb, 1996).  
In other cases of MS, the patient exhibits immediately with all the symptoms and it is 
very easy to quickly and accurately diagnose MS (Fleming, 2002). The current generally 
recognized protocol for diagnosis requires the patient to exhibit two or more white-matter 
lesions, two or more recognizable neurologic symptoms (or two or more exacerbations 
[flare-ups] that exhibited these symptoms – neurologic symptoms may not be evident 
between flare-ups) and an increase of Immunoglobulin G (which is the main antibody the 
immune system uses to control infection in body tissues) in the spinal fluid (American 
College of Sports Medicine, 2002). Typically a concrete diagnosis requires both an MRI 
to detect lesions and a lumbar puncture for the collection of spinal fluid. The type of MS 
the patient is initially diagnosed with is determined by the number, location and type of 
lesions, symptoms exhibited, and the existence of exacerbations and remissions (Fleming, 
2002). The form of the disease may change over the lifetime of the patient and diagnosis 
is a dynamic and ongoing process (Fleming, 2002; Halper & Holland, 1996; Kalb, 1996). 
Types of MS. MS is unpredictable in its progression and can take a number of 
different forms (Pakenham, 2006).  The symptoms of MS can range from abnormal 
sensation (tingling, numbness), vision problems, fatigue, muscle weakness (more often in 
lower extremities because lesions tend to occur low on the spinal cord), motor skill 
problems, coordination, ataxia (speech problems), bladder and bowel problems, heat 
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sensitivity, chronic pain, vertigo and hearing problems, sexual dysfunction, and cognitive 
problems (Fleming, 2002; Kalb, 1996; National Library of Medicine, U.S., 2000; Sheet, 
2006). As previously discussed, symptoms depend on the location and severity of the 
lesions and for this reason no two cases of MS are exactly the same. In spite of the drastic 
differences in MS symptoms from patient to patient, there are four different generally 
agreed upon classifications of the disease.  
The most common form of MS is relapsing-remitting MS (RRMS), which is 
characterized by flare-ups where the patient experiences symptoms such as loss of 
coordination and cognitive functioning, fatigue, numbness, and weakness, followed by 
relapses in which the level of functioning returns to near normal (figure 4) (Fleming, 
2002; Iezzoni, 2010). The flare-ups are called exacerbations (Iezzoni, 2010). These 
relapses tend to shorten, and normal functioning levels decrease as the disease progresses. 
Approximately 85% of patients diagnosed with MS initially present with RRMS and of 
these, 2 out of 3 are women (Coyle & Hamaad, 2006; Fleming, 2002; Iezzoni, 2010; 
Kalb, 1996). Particularly in RRMS, the stochastic nature of symptoms can make the 
initial MS diagnosis difficult (Fleming, 2002; Iezzoni, 2010). Individuals have vague 
symptoms that come and go (these are flare-ups where the myelin and axon are being 
damaged and then consequently repaired) and the symptoms are not consistent between 
patients. MS symptoms such as blurred vision, fatigue, weakness, and numbness can be 
attributed to many different diseases so when the patient does see a doctor, if an MRI is 
not ordered for diagnosis,  it is not always clear what the underlying cause is (Kalb, 
1996). It is not uncommon for an individual to live for years with mild RRMS before 
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being diagnosed. Often, symptoms are minor and sporadic so the patient does not seek 
medical advice until the disease has progressed to a point where it is obvious that there is 
a problem (Iezzoni, 2010).  
Most cases of MS start as RRMS but eventually the disease evolves into 
secondary-progressive MS (SPMS) (Coyle & Hamaad, 2006; National Library of 
Medicine, U.S., 2000). SPMS is characterized by steady decline in functioning with 
possible short relapses between flare-ups. As depicted in figure 4, SPMS begins as 
RRMS and then at some point transitions to a more steady decline similar to other forms 
of the disease. Not all cases of RRMS develop into SPMS, and the timeline may be many 
years before this change occurs, but over time this evolution occurs in a majority of 
patients (Fleming, 2002).  
A more aggressive form of MS is progressive-relapsing MS (PRMS). In this form, 
MS is characterized by constant progression of symptoms from the onset of disease with 
few relapses (figure 4) (Iezzoni, 2010). The relapses that are seen are brief and do not 
take the functional level of the patient back to normal levels. This type of MS only affects 
about 5% of cases. Patients with PRMS are typically diagnosed later in life (after the age 
of 40) and, unlike other forms of the disease, are equally distributed between genders 
(Coyle & Hamaad, 2006).  
Finally, primary-progressive MS (PPMS) is characterized by steady worsening of 
symptoms from onset with no relapses (“What is MS?,” 2012). Patients with this type of 
MS make up about 10% of cases and have the worst prognosis for treatment and disease 
control. As seen in figure 4, once symptoms begin there is no reprieve, and decline of 
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functioning is at a steady rate. Lesions in PRMS are located on both the spinal cord and 
in the brain and are numerous from the onset (Fleming, 2002). Patients with either PPMS 
or PRMS have very little luck with the drug therapies that are used to control MS 
progression (Wagstaff, 2000). 
 
 
Figure 4. Graphical Representation of the Four Types of MS. 
 
 
Treatment Protocols for MS 
MS progresses over time and there is no known cure. The only treatments 
currently available are designed to control symptoms to improve quality of life. MS can 
have a significant negative impact on both cognitive functioning and physical ability 
(Patti, 2009). The impact that this disease has on an individual’s ability to function and 
live a happy and productive life varies greatly depending on the type and progression of 
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the disease, and it is imperative that early and effective treatments are implemented for 
individuals with MS. MS treatments have one of three goals (a) treating symptoms of an 
acute flare-up in order to return the patient to pre-flare-up functioning, (b) addressing 
long-term disease progression to slow the advancement, or (c) treating the secondary 
symptoms of MS such as numbness, vision problems, etc. (Halper & Holland, 1996; 
Iezzoni, 2010). Due to the varying nature of MS, treatment protocol options are also 
widely varied. Current treatment can be categorized into four basic categories, drug 
protocols, PA interventions, non-traditional medicine, and diet modifications (Halper & 
Holland, 1996). For the purposes of this examination we are going to briefly examine 
drug protocols and focus primarily on PA interventions. Diet modifications and non-
traditional medicine are extremely multifaceted, still widely controversial, and often lack 
an evidence base; therefore they fall beyond the scope of this paper.  
 Drug Therapies. The three goals of drug therapies are treatment of acute flare-
ups (symptomatic treatment), long term disease management – referred to as Disease 
Modifying Treatment (DMT), and secondary symptom control. This paper will briefly 
discuss the treatment protocol of acute flare-ups and long-term disease progression; it 
will not discuss treatments for secondary symptoms. The drug protocols that address 
secondary symptoms are numerous and do not directly relate to the focus of this 
examination. 
An acute flare-up, also known as an exacerbation, is classified as any time an MS 
patient begins experiencing a heightened level of acute MS symptoms that they do not 
normally experience (Fleming, 2002; Kalb, 1996). It is important to get an exacerbation 
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under control quickly to minimize the neural damage that is occurring as lesions are 
forming in the nervous system (Halper & Holland, 1996). Acute flare-ups are treated with 
glucocorticoids, a four-ringed steroid molecule with strong anti-inflammatory and 
immunosuppressive qualities, with the purpose of hastening recovery from the 
exacerbation (Coyle & Hamaad, 2006; Wagstaff, 2000). Steroid use is not a long-term 
treatment option as the high doses necessary have a number of acute side effects 
including insomnia, extreme emotional fluctuations, fluid retention, weight gain, cardiac 
arrhythmia, hypertension, hyperglycemia, and increased susceptibility to infection (Coyle 
& Hamaad, 2006). Steroids can be administered orally or intravenously with both 
methods appearing to elicit similar results in controlling exacerbations (Wagstaff, 2000).   
Long-term treatments for MS focus on altering the immune system response to 
the disease. Current DMTs rely on the assumption that MS is an autoimmune disease that 
is attacking the body’s nervous system. As such, the goal of DMT is to control the 
immune system response to the perceived threat to the body (Coyle & Hamaad, 2006; 
Fleming, 2002; Wagstaff, 2000). The current DMTs include immunomodulators (drugs 
that modulate the immune system response in some way) and immunosuppressives 
(drugs that specifically slow or inhibit the body’s natural immune system response) 
(Kalb, 1996). Immunomodulators are the most commonly used DMT for treating MS 
because they are less destructive to the immune system as a whole. Immunomodulators 
tend to be more focused on specific types of  immune system functions while leaving 
other types of functions intact (Talley, 2008). Typically immunosuppressives are a last 
resort for patients who are not responding to standard immunomodulator treatments 
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(Coyle & Hamaad, 2006; Kalb, 1996). Immunosuppressives can be very effective in the 
control of MS progression but do leave the patient more susceptible to other infections 
(Talley, 2008). 
It is important to realize that the success of DMTs is primarily limited to patients 
with RRMS. Once the disease progresses to SPMS or takes the form of PPMS or PRMS 
the effectiveness of these therapies is marginal at best (Fleming, 2002). It is for this 
reason that it is imperative to find ways for patients to remain in the RRMS phase of their 
disease as long as possible. Once MS progresses, treatments and control are not nearly as 
successful. In conjunction with drug therapies, another means to delay MS progression is 
through the incorporation of a PA protocol.  
Physical Activity. PA is defined as anything that increases heart rate, 
incorporates large muscle group movement, and gets the body moving (“Physical 
Activity Guidelines for Adults,” 2014). There is a growing body of research surrounding 
the implementation of PA as a supplemental treatment for MS patients who are sedentary 
(White & Dressendorfer, 2004).  A review of this research shows that muscular strength, 
aerobic capacity, walking performance, quality of life, fatigue, balance and gait are all 
improved (Motl & Pilutti, 2012). For example, research by Levy, Li, Cardinal, and 
Maddalozzo (2009) demonstrated a significant reduction in physical symptoms in 
sedentary female MS patients when the patients exercised for one year. Dalgas et al. 
(2009) showed improvement in functional strength and capacity in moderately impaired 
MS patients after a 12-week lower extremity strength program. A recent meta-analysis 
showed small but significant improvements in walking mobility in patients who 
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participate in exercise programs of all types (Snook & Motl, 2009). This research all 
points to symptom improvement when PA is incorporated into the lives of individuals 
with MS, for this reason, exploration into the specifics surrounding PA protocols needs to 
continue to be a focus.  
PA also has a direct effect on frequency, intensity, and duration of MS symptoms 
(White & Dressendorfer, 2004).  Specifically, PA has been shown to reduce MS flare-ups 
(Motl & Snook, 2008; Petajan et al., 1996). There is also growing evidence that long-
term PA aids in slowing the progression of MS.  Stuifbergen, Blozis, Harrison, and 
Becker (2006) demonstrated a significant reduction in long-term disease progression in 
patients who exercised for a 5-year period. This research points to reasons why it is 
beneficial for PA to be incorporated into the lives of individuals living with MS.  
Increased fatigue is a symptom often seen in individuals with MS; however 
research has shown that overall fatigue levels are not affected by PA participation, 
meaning that PA can be incorporated into daily activity without concern for increased 
fatigue (van den Berg et al., 2006). A recent meta-analysis found a reduction in overall 
fatigue levels in individuals with MS when they were placed on an exercise program 
suggesting that PA could actually be used as a means to decrease fatigue levels (Pilutti, 
Greenlee, Motl, Nickrent, & Petruzzello, 2013).  Fear of increased fatigue levels is often 
cited as one of the reasons that individuals with MS shy away from PA; thus, the 
aforementioned research showing a decrease in fatigue is promising for PA interventions 
(Lee, Newell, Ziegler, & Topping, 2008).  
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In addition to physical benefits, there is some evidence that PA participation may 
increase cognitive functioning, psychological coping skills, and overall quality of life in 
MS patients, although findings are mixed. Motl, Gappmaier, Nelson, and Benedict (2011) 
examined the association between PA and various cognitive functions in MS patients. 
They found that an intervention that increased PA in sedentary MS patients correlated 
with improved cognitive processing speed. This research suggests that PA may be 
beneficial as a treatment for the cognitive impairments of MS as well as for the physical 
impairments. 
PA recommendations for individuals with MS. A systematic review of PA 
interventions with MS patients established recommended PA guidelines for adults with 
mild to moderate MS; these guidelines recommend a minimum dose of PA required to 
improve fitness, increase mobility, improve QOL, and decrease fatigue (Latimer-Cheung 
et al., 2013). The specific recommendations are at least 30 minutes of moderate intensity 
aerobic exercise twice per week and strength training for all the major muscle groups at 
least twice per week. Currently only a small number of individuals with MS report 
meeting these guidelines (Klaren, Motl, Dlugonski, Sandroff, & Pilutti, 2013). Current 
recommendations from the ACSM (2002) suggest the same amount of PA for individuals 
with MS and other chronic neurologic diseases as is recommended for the general public 
– 30 minutes of PA most days with both aerobic and strength workouts included. 
Although these two sources for PA recommendations are not exactly the same, they both 
similarly prescribe regular aerobic and strengthening exercises and suggest that the 
guidelines are the minimum necessary for health benefits. In addition to these 
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recommendations, stretching may be important for MS patients because of the limited 
range of motion that is often experienced due to muscle spasticity (American College of 
Sports Medicine, 2002). 
Special considerations in PA prescription for MS patients. The American 
College of Sports Medicine (ACSM) (2002) suggests some special considerations when 
incorporating a PA program into the lives of individuals with MS. Heat sensitivity is a 
big concern in the daily lives of the vast majority of MS patients (Iezzoni, 2010). 
Increases in external (environmental air temperature) and/or internal (body) temperature 
magnifies MS symptoms, especially increasing fatigue and coordination problems 
(American College of Sports Medicine, 2002). It is recommended that PA be limited to 
locations where ambient air temperature is cool and that aerobic PA be limited to 
moderate intensity to prevent overheating. Climate controlled gyms and temperature 
controlled swimming pool workouts may be good options for this. The ACSM (2002) 
also suggests that PA be focused on the individual’s physical capabilities. Coordination 
problems are often seen in MS patients; for this reason it may become necessary to alter 
both aerobic exercise (e.g. stationary bicycle versus treadmill) and strength exercises (e.g. 
weight machines versus free weights) in order to accommodate physical limitations and 
promote successful participation for the individual (ACSM, 2002). Sensory perception is 
also sometimes lost or diminished in MS patients; in conjunction with coordination issues 
this can pose a safety issue while participating in certain activities.  For this reason, it is 
recommended that any individual with MS is closely supervised when introduced to new 
forms of PA to insure they can safely execute the activity (ACSM, 2002).  
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Quality Of Life Benefits of PA in MS Patients 
There is a growing body of research surrounding quality of life benefits from PA 
participation in MS patients. Individuals who are physically active report increased 
physical and cognitive ability and this can translates into higher reported quality of life 
(Motl & Snook, 2008). For instance, Motl and McAuley (2009) found in a 6 month study 
using accelerometer data that individuals who were more active reported improved 
quality of life, a reduction in pain and fatigue, and an increase in social support and self-
efficacy. After a PA intervention using progressive weight training, women with MS 
reported improvements in strength, walking ability, and daily activity functioning. In 
qualitative interviews, these women all reported an increased quality of life with the 
perception that this was a result of these physical improvements (Giacobbi, Dietrich, 
Larson, & White, 2012). Physical activity has also been reported to increase 
psychological quality of life through interventions that increased self-efficacy in 
participants (Motl, McAuley, Wynn, Sandroff, & Suh, 2013). In contrast to the above 
findings, Romberg, Virtanen, and Ruutiainen (2004) did not find significant 
improvements in reported quality of life in MS patients after a PA intervention, even 
when participants reported functional improvement. The research by Romberg and 
colleagues only examined physical quality of life changes from PA participation and did 
not focus on quality of life factors associated with cognitive improvements or 
psychological constructs. It is possible that this is the reason that there was not a reported 
increase in quality of life.  It appears that most research points to improvements in both 
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physical and cognitive functioning through PA participation and this can have a 
significant impact on overall quality of life (Ellis & Motl, 2013). 
In conjunction with this increased quality of life, a positive attitude and a positive 
mental approach have been linked to reductions in MS symptoms (Motl & Snook, 2008). 
MS patients with a positive outlook about their disease have been shown to have a 
reduction in the number of flare-ups they experience over time (Levy, Li, Cardinal, & 
Maddalozzo, 2009). MS patients are prone to depression and as a population exhibit 
higher than average levels of depression and other similar psychological disorders 
(Pakenham, 2006). Positive life experiences reduce depressive symptoms in MS patients. 
The more positive life experiences they reported, the less depression they reported, 
regardless of their level of functioning (Phillips & Stuifbergen, 2008). Collectively, this 
research suggests that when exercise is a positive experience, it can improve quality of 
life.  
A recent meta-analysis of the research confirms this positive impact of PA on 
quality of life (Motl & Gosney, 2008). It appears that PA could play a role in symptom 
management and, consequently, positively influence overall quality of life (Motl & 
Pilutti, 2012). Participants in PA programs report higher levels of functioning and overall 
quality of life than non-physically active controls (Sutherland, Andersen, & Stoové, 
2001). Furthermore, when exercise improves physical performance, self-efficacy also 
improves (Motl & Snook, 2008). This scenario creates a PA – self-efficacy cycle that 
propagates itself to create an improved QOL. Considering all of the findings surrounding 
PA and physical, cognitive, and psychological benefits in tandem, it seems that 
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intervention in the form of a PA protocol is important in order to maintain mobility as 
long as possible and increase improvements in long-term prognosis.  
Physical Inactivity and the MS Population 
The aforementioned body of research would suggest that PA should be an integral 
part of treatment for individuals with MS. Contrary to this, individuals with MS are a 
largely sedentary population (Sandroff et al., 2012). As discussed, PA has been shown to 
help minimize both physical and cognitive MS symptoms and increase quality of life. 
Unfortunately, due to the physical limitations experienced as a result of MS, many 
individuals avoid PA after diagnosis with MS (Motl & Snook, 2008; Petajan et al., 1996). 
Individuals with MS are less physically active than the general population and less active 
than individuals with other chronic conditions such as diabetes and Parkinson’s disease 
(Motl, McAuley, & Snook, 2005; Nortvedt, Riise, & Maeland, 2005).  Research indicates 
only 19.5 % of individuals with MS report meeting the public health guidelines for 
moderate to vigorous PA (Klaren et al., 2013). Additionally, the less ambulatory the MS 
patient is, the less likely they are to participate in PA (Klaren et al., 2013). The 
problematic nature of this juxtaposition of PA and mobility suggests an inactivity cycle 
that propagates itself; the individual is physically inactive because of limited mobility and 
the lack of PA contributes to the reduction of mobility.  
High levels of self-efficacy have been shown to have a positive effect on MS 
patients’ motivation for PA participation (Dlugonski, Motl, Mohr, & Sandroff, 2012; 
Ellis & Motl, 2013). Individuals with MS who report higher self-efficacy for PA also 
report higher levels of PA participation, and PA interventions that have been designed 
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around increasing self-efficacy are more successful than interventions that are only based 
on PA participation without the self-efficacy component (McAuley et al., 2007; Motl, 
Dlugonski, Wójcicki, McAuley, & Mohr, 2011). For this reason, it is imperative that any 
PA interventions include a focus on psychological motivators as well as perceived 
physical benefits.  
Theories of Behavior Change 
 When examining behavior motivation, it is important that a theoretical framework 
is used to guide understanding and methodology. A great deal of recent literature on 
motives for PA participation has centered on cognitive theories (Dugdill, Crone, & 
Murphy, 2009; Roberts & Treasure, 2012; Young et al., 2014). For the purposes of this 
review, two of these theories will be explored: Social Cognitive Theory (SCT), which has 
encompassed most of the existing theoretical behavior change research specific to MS 
and PA (Motl, 2014), and Self-Determination Theory (SDT), which the current research 
posits may be a better theoretical model for determining motivational outcomes in MS 
patients.  
Social Cognitive Theory 
According to SCT, there are certain psychological variables that are necessary for 
any health behavior to occur (Bandura, Adams, & Beyer, 1977). One of the variables that 
is a proven method of increasing PA participation is self-efficacy (Bandura, 1997). Self-
efficacy is the belief of the individual that they are competent and confident in 
successfully executing a given task in a given situation (Bandura et al., 1977). Self-
efficacy is situation specific and varies according to the perceptions the individual has 
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surrounding his or her abilities to execute the task. Accordingly, individuals have a 
tendency to engage in activities that they feel they can be successful at, including PA 
behaviors (Bandura, 2004; Young et al., 2014). This self-efficacy then increases the 
individual’s outcome expectations for the behavior in question (in this case PA 
participation) and motivation for continuation of the behavior results. Based on SCT, if 
we can increase self-efficacy in sedentary individuals in order to facilitate confidence in 
PA ability, we will increase PA participation. Furthermore, individuals who are 
physically active should exhibit high levels of self-efficacy for PA and have strong 
outcome expectations for successful participation.  
In support of SCT as a predictor of motivation for behavior, self-efficacy has been 
shown as a correlate of PA in individuals with MS (Suh, Weikert, Dlugonski, Balantrapu, 
& Motl, 2011; Young et al., 2014) and SCT theory has been repeatedly used to 
successfully create and implement behavior change interventions in individuals with MS 
(Motl, 2014). Interventions where participants received SCT-based information via phone 
and newsletter showed significant increases in PA participation (Suh, Motl, Olsen, & 
Joshi, 2015). An 18-month longitudinal study to assess social cognitive variables showed 
that a significant change in self-efficacy and goal setting had an indirect effect on PA 
participation, supporting SCT as an effective means for changing behavior (Suh et al., 
2011). In relation to physical wellness and SCT, results from a 6-month longitudinal 
study showed that after a 3-day, intensive, multidisciplinary, social-cognitive wellness 
intervention, participants showed improved self-efficacy and enhanced autonomy for 
wellness behaviors 6-months post-intervention (Jongen et al., 2014). Examining the 
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relationship between symptoms, PA, and self-efficacy using SCT shows a positive 
relationship between self-efficacy and PA, and a negative relationship between symptoms 
and PA and symptoms and self-efficacy (Motl, Snook, McAuley, & Gliottoni, 2006). All 
of this research points to SCT as an effective predictor of PA participation in individuals 
with MS and an effective theoretical background for designing interventions.  
Self-Determination Theory 
It can be argued that SDT is similar to SCT in assessing quantity of motivation, 
the difference being that SDT is also focused on the type of motivation. As previously 
discussed, SCT views motivation as a singular construct with variation in only the 
quantity of motivation (Standage & Ryan, 2011). In contrast, SDT is a theory of behavior 
motivation based on varying levels of both quantity and type of motivation (Deci & 
Ryan, 1985, 2004; Standage & Ryan, 2011). When looking at motivation, SCT asks “how 
much”; SDT asks “how much and what kind?” By examining both the amount and type 
of motivation, SDT allows for a more detailed analysis of the drive for behavior.  
SDT posits that people have a natural desire to behave in an effective and healthy 
way – the driving force behind this behavior is self-determination 
(“selfdeterminationtheory.org — An Approach to human motivation & personality,” 
2015).  The more self-determined an individual is, the more internalized the motivation 
for behavior. Self-determination is realized through satisfying the basic need for 
competency, autonomy, and relatedness. If individuals feel competent at what they are 
doing, feels they are doing it as their own choice, and feel related to others in the same 
behavior, then the behavior becomes self-determined and will continue (Deci & Ryan, 
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1987). Deci also argues that autonomy is the most important of these three constructs and 
as such, has spent the last 20 years developing ways to isolate the best methods to 
develop an autonomy supportive climate in hierarchical situations (Deci & Flaste, 1996).  
According to SDT, the key to understanding behavior is understanding the type of 
motivation the individual possesses. More specifically, SDT asks where the motivation 
for the activity originates. It is not enough for the individual to feel self-efficacious for 
the ability to complete a behavior, the self-efficacy also needs to come from a 
(personally-determined) sense of autonomy in the behavior. The more autonomous an 
individual is, the more internal (self-determined) the motivation for the activity. As 
autonomy is removed, the motivational source for the activity becomes more externally 
influenced and less self-determined. An example of this is the individual who is 
participating in PA because they are being told to do so by someone else. They may have 
confidence that they can be active (high self-efficacy) but because their motivation is 
externally controlled, the likelihood that PA is going to remain a lasting behavior is 
reduced. Motivation in SDT is measured on a continuum. The SDT motivation 
continuum ranges from amotivation (lack of motivation for the activity) to extrinsic 
motivation (motivated by external forces), to intrinsic motivation (performance of the 
activity for the enjoyment of the activity) (Frederick-Recascino & Schuster-Smith, 2003).  
Extrinsic motivation is a multidimensional construct that is divided into four levels: 
external regulation, introjected regulation, identified regulation, and integrated regulation. 
These levels represent a continuum of self-regulation which spans from complete 
external regulation to almost completely internal regulation (Ryan & Deci, 2000). The 
 
 
 
32 
 
 
more internally regulated the motivation, the closer the individual is to an intrinsic 
motivation for participation. An individual does not exhibit complete internal regulation 
of their motives for participation in their activity until they are intrinsically motivated. 
See Table 1 for brief definitions of the complete motivation continuum and Table 2 for a 
visual representation of this continuum. 
 
Table 1. Brief Definitions of SDT Levels of Motivation 
Motivation level: Definition: 
Amotivation No motivation for the activity 
External regulation Motivated by outside sources (doctor’s orders) 
Introjected regulation Motivated by obligation (guilt) 
Identified regulation  Motivated by activity benefits (fitness gain) 
Integrated regulation Motivated by identification (I am a…) 
Intrinsic motivation Motivated by the enjoyment of the activity 
 
 
Table 2. Motivation Continuum 
Amotivation Extrinsic Motivation Intrinsic 
Motivation 
 External 
Regulation 
Introjected 
Regulation 
Identified 
Regulation 
Integrated 
Regulation 
  
<--Continuum of Self-determination --> 
 
 
It is important to understand the motivation continuum in order to fully grasp 
SDT. Knowing how self-determined the individual is will provide the information 
necessary to answer the research questions. This project uses both global self-
determination and the motivation continuum to assess motivation. The more self-
determined the individual is the closer they fall to the intrinsic end of self-determination 
and therefore the more likely they are to participate in PA.   
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SDT and PA 
 SDT has been used in numerous settings to effectively assess motivation for 
behavior. Specific to the purpose of this research, SDT has been shown to be an effective 
means for evaluating motivation for PA participation in numerous settings (Standage & 
Ryan, 2011). For instance, in breast cancer survivors, SDT has been shown to account for 
20% of the variance in PA participation and was considered a useful predictor in 
understanding PA participation in this population (Milne, Dodd, Guilfoyle, Gordon, & 
Corneya, 2008). Autonomous motivation (self-determined motivation) has been found to 
predict PA participation in a number of different populations including pregnant women 
(Gaston, Wilson, Mack, Elliot, & Prapavessis, 2013), cancer survivors (Wilson, 
Blanchard, Nehl, & Baker, 2006), overweight individuals (Silva et al., 2010), and at-risk 
children (Curran, Hill, & Niemiec, 2013). A systematic review of 66 studies consistently 
showed high levels of self-determined motivation for PA in individuals who were more 
autonomous in their participation. According to the findings of this review, the more self-
determined the individual is, the more likely it is they will maintain long-term PA 
participation (Teixeira, Carraça, Markland, Silva, & Ryan, 2012). Collectively, this 
research provides support for the continued use of SDT as a valuable and effective means 
of examining motivation for PA. For this reason, it is appropriate to use SDT in this 
project as a means to examine PA motivation.  
Research Using SDT to Examine PA in MS Patients 
 Leading up to the current research, two previous projects examined PA 
motivation in MS patients using a SDT framework. A 2013 case study with one highly 
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physically active woman with MS explored the role of athletic participation in her life 
(Fasczewski, Gill, & Barrett, n.d.). This case study was designed to gain insight into how 
self-perceptions and psychological skills aided the individual in meeting the challenges 
posed by her disease. The participant was a 51-year old competitive elite amateur 
mountain bike racer who was diagnosed with MS when she was a teenager. Results 
suggest that she saw high self-efficacy, mental toughness and a positive outlook as keys 
to success in sport and in life, and that her participation in athletics strengthened her 
overall quality of life.  
Although SDT was use as a framework for the analysis of the aforementioned 
case study, the open-ended interviews left many unanswered questions regarding motives 
for PA participation. In order to examine these questions further, a second study, 
designed as a pilot study for the current project, was done to explore the use of specific 
SDT measures with the MS population. This pilot study examined a larger sample of 
highly active people with MS. Self-efficacy and the basic needs of competence, 
autonomy and relatedness, and quality of life were explored as they relate to motivation 
and participation in high levels of PA using surveys and semi-structured interviews 
(Fasczewski, Gill, & Rothberger, n.d.). The interviews focused on a) motivation and 
strategies used to maintain physical activity, and b) the benefits and impact of PA in their 
lives. All participants were highly motivated to participate in PA, and the main themes 
were in line with SDT; participants described feelings of accomplishment and 
competence in both their PA and daily life, as well as a sense of independence and 
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autonomy.  All participants also reported high overall quality of life and attributed this in 
part to their PA participation.  
The results from these projects provided insight into the motives for PA 
participation in an active sample of people with MS and lend support for future research 
using SDT as a framework for understanding this motivation.  It now becomes important 
to expand this research to understand these motives for the entire MS population. This is 
the first step in developing a SDT-based PA intervention.  
Summary 
This project is unique because it explores PA motivation in the MS population 
through the lens of SDT and self-efficacy. It is especially relevant because the MS and 
PA research that has been done previously relies on SCT as a theoretical backdrop. SDT 
can provide an additional, in-depth examination of the motives for PA participation that 
cannot be gained through solely using SCT by explaining both the amount and type of 
motivation. Modeling this relationship will allow for the development of future 
interventions with MS patients by lending insight into the important aspects of this 
relationship. Before any intervention can be developed, the relationship between SDT 
and PA participation needs to be understood; and that is what this project is designed to 
do. Finding ways to promote PA within this population is an important part of disease 
management long-term for these individuals.  Through this type of understanding and 
eventual intervention, disease symptoms can be better controlled and therefore overall 
quality of life will be enhanced for MS patients.  
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CHAPTER III 
METHODS 
 
 
 The purpose of this study is to examine self-determined motivation, self-efficacy, 
PA participation, and quality of life in individuals with MS. Specifically, structural 
equation modeling techniques were used to model the relationships among self-
determined motivation, self-efficacy, PA, and quality of life. Survey methods were used 
with a large sample of people with MS to obtain measures of motivation, PA, and quality 
of life.  
Participants 
The original plan for recruitment relied on using mass email distribution from the 
North American Research Committee on Multiple Sclerosis (NARCOMS) registry. The 
NARCOMS registry is a voluntary, self-report registry where individuals with MS 
complete an enrollment questionnaire and biannual surveys and then can be identified by 
the registry as potential research participants in projects that are applicable to the 
individual. NARCOMS was contacted with study details and participant parameters upon 
receipt of IRB approval. Unfortunately, NARCOMS was unable to provide access to their 
database in a timely manner; they offered assistance beginning in August of 2016. Due to 
the timely nature of the project, the National Multiple Sclerosis Society (NMSS) was 
contacted regarding research assistance. The NMSS approved the study for distribution 
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and posted information and the survey link on the NMSS website (www.nmss.org) under 
the ongoing research page. Additionally, all 34 NMSS regional chapters were contacted 
via email explaining the study and asking for assistance in distribution. Nine chapters 
responded and agreed to help; of those 9, 6 (North Carolina/South Carolina, Georgia, 
Alabama, Ohio, Northern California, Gateway Area) sent the link directly to support 
groups for distribution directly to members and 3 (New England, Indiana, NY 
City/Southern New York) placed the link in email blasts/monthly newsletters. 
Concurrently, a social media flyer was shared via Facebook (www.facebook.com). This 
flyer was posted as a “public” flyer, meaning that it could be seen and shared by anyone 
on Facebook. It was shared by 37 different individuals.  
Participants were individuals between the ages of 18 and 65 years who have had 
MS for at least 1 year. This one-year requirement was to insure that they are not still in 
the initial acute flare-up that prompted diagnosis and have had time to live with MS. 
Because MS impacts each individual differently, there was no reason to restrict age for 
symptom-related reasons and individuals at any age can be physically active. Targeting 
this wide age range increased the likelihood of obtaining more data to increase statistical 
power, leading to meaningful, generalizable results. There was no restriction on disease 
progression, form, or PA level.  
Measures 
Established measures of disease step, self-determination, self-efficacy for PA, and 
quality of life were used to assess the main variables. Basic demographic measures (age, 
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gender, disease step, time since diagnosis) were also used. Open-ended questions about 
PA, MS, and quality of life were included to allow participants to tell their experiences in 
their own words.  
Disease Assessment and Physical Abilities 
Patient-Determined Disease Step (PDDS) – The PDDS is a single question 
ordinal scale that asks participants to self-rate the severity of their disease symptoms 
from 0 – Normal: “I may have some mild symptoms, mostly sensory due to MS but they 
do not limit my activity. If I do have an attack, I return to normal when the attack has 
passed” to 8 – Bedridden: “Unable to sit in a wheelchair for more than one hour” (Hohol, 
Orav, & Weiner, 1995, 1999). Each of the 9 PDDS rating numbers (0-8, higher being 
more disabled) corresponds with a description of that disability rating and the patient is 
asked to rate their disease symptoms as closely as possible to the descriptions provided. 
The PDDS was developed as a self-report reflection of the clinical standard Expanded 
Disability Status Score (EDSS) neurological assessment done by physicians. The EDSS 
is an in depth neurological physical exam that provides medical personnel with an overall 
rating number between 0 and 10 with the higher number being more disabled (Kuttzke, 
1983). Using the PDDS is an effective method to gather similar information in self-report 
situations. Validation of the PDDS has determined that it is an effective alternative means 
for assessing disease step for patients with MS (Learmonth, Motl, Sandroff, Pula, & 
Cadavid, 2013). It has been used extensively by the Exercise Neuroscience Research Lab 
at the University of Illinois (one of the leading labs in the US for MS research) for this 
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purpose. Overall PDDS and EDSS scores were highly correlated (r = .783), making it a 
viable tool for determining patient reported outcomes of MS symptoms in survey 
research (Learmonth et al., 2013). For this project, the PDDS was used to categorize 
individuals into two groups – the first group can be classified as minimally disabled 
individuals (scores 0-3), and the second group as functionally disabled individuals (scores 
4-8). The decision to dichotomize these results was based on previous research that 
shows a significant drop in PA participation when individuals reach a disability level that 
limits functional mobility (Klaren et al., 2013). The cut off on the PDDS for mobility is 
between 3 and 4.  
Physical Activity Level 
Godin Leisure-Time Physical Activity Questionnaire (Godin) – The Godin is a 
3-question, self-report measure that assesses the frequency that individuals engage in 
bouts of PA at light, moderate, and strenuous levels (Godin & Shephard, 1985). The 
measure asks frequency of PA at each activity level and uses a formula to calculate a 
score (MET value) for weekly activity (9 x strenuous, 5 x moderate, and 3 x light). The 
higher the overall score, the greater the PA level. The MET scores can also be used to 
classify PA participation into three categories: “active” (24 and higher), “moderately 
active” (14-23), and “insufficiently active” (less than 14). More recently, research has 
proposed using only using the moderate and strenuous calculations to classify individuals 
as “active” (≥ 24 METS) and insufficiently active” (≤ 23 METS) to fall in line with PA 
guidelines in both the United States and Canada (Amireault & Godin, 2015; Godin, 
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2011). For the majority of analyses in the current research, the total MET score as a 
continuous variable will be used. It is also important to know if participants who report 
being active (when asked “are you physically active”) are really participating in the 
recommended amount of moderate to vigorous PA as defined by MET scores. To 
understand this, participants will be classified as active and inactive. The Godin measure 
has good test–retest reliability (.84) (Godin & Shephard, 1985) and reviews of PA 
measures support its use (e.g., Jacobs, Ainsworth, Hartman, & Leon, 1993). It is one of 
the leading self-report measures of PA (Godin, 2011). 
Self-Determined Motivation 
The Behavioral Regulation in Exercise Questionnaire – Version 2 (BREQ-2) 
– The BREQ-2 is a multidimensional scale based on the motivation continuum in SDT, it 
includes amotivation (not motivated at all), external motivation (motivated by rewards 
and punishments), introjected motivation (motivated by feelings of guilt or self-worth), 
identified motivation (motivated by the value and importance of the activity to personal 
goals), and intrinsic motivation (motivated by the inherent enjoyment of the activity) 
(Markland & Tobin, 2004). The BREQ-2 is measured on a 5 point Likert-Type scale with 
5 being high, each subscale has 4 questions except for the introjected regulation scale 
which only has 3 questions and is calculated individually for examination of the different 
levels of motivation. The Cronbach’s alpha for each subscale was reported as follows: 
amotivation (.83), external motivation (.79), introjected regulation (.80), identified (.73), 
and intrinsic motivation (.86), showing good internal consistency for all subscales 
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(Markland & Tobin, 2004). Results from confirmatory factor analysis indicate the 
BREQ-2 scale had good factorial validity with all the factors loading moderate to strong 
(M = .76, range = .53-.90; p’s < .001) (Markland & Tobin, 2004). Integrated regulation 
(motivated by identification with the activity) is clearly absent from this scale. This is 
because many researchers have been unable to distinguish between integrated regulation 
and intrinsic motivation in PA (Mallett, Kawabata, Newcombe, Otero-Forero, & Jackson, 
2007). During the development of the BREQ-2 these two constructs could not be reliably 
individually determined (Markland & Tobin, 2004). There has been some recent evidence 
of development of a reliable scale for integrated regulation (McLachlan, Spray, & 
Hagger, 2011) but results have been limited and there is currently little support for using 
it with  specialized populations. For this reason the BREQ-2 was used as designed with 
the 5 subscales.  
Self Determination Scale (SDS) – The SDS is a 10-item scale with two, 5-item 
subscales. The subscales, sense of self and perceived choice in one’s actions, can be used 
individually or combined for an overall self-determination score (Sheldon & Deci, 1996). 
The SDS assesses individual differences in the manner in which people function in self-
determined ways. Each item is a pair of scenarios that contradict one another (e.g., I am 
free to do whatever I do; what I do is often not what I’d choose to do). The responses are 
measured on a 5-point scale with each pair of scenarios scored from 1 (only A feels true) 
to 5 (only B feels true). See Figure 5 for sample questions. According to SDT, the more 
self-determined an individual is, the more intrinsically motivated they are for the 
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behavior in question (in our case PA) and therefore the more likely they will participate 
(Deci & Ryan, 2004). The SDS has demonstrated good internal consistency, with alphas 
ranging from .85 to .93, adequate test-retest reliability (.77), and has been widely-used 
(Sheldon, Ryan, & Reis, 1996). This scale was used as a measure of overall self-
determination in all aspects of the individual’s life. The SDS was included in the analyses 
to examine self-determination as a global trait, unlike the BREQ-2 that examines self-
determination as a more situation-specific trait. This difference is important to consider 
because overall quality of life could be impacted differently depending on the nature of 
self-determination, for this reason both scales were used.  
 
SDS Example Question – Perceived Choice 
A. I always feel like I 
choose the things I 
do. 
 B. I sometimes feel like it’s 
not really me choosing the 
things I do.   
Only A feels true 1          2          3          4          5 Only B feels true 
 
SDS Question – Sense of Self 
A. I feel that I am 
rarely myself. 
 B. I feel like I am always 
completely myself.   
Only A feels true 1          2          3          4          5 Only B feels true 
Figure 5. Example of SDS Question Style and Format 
 
 
Self-Efficacy 
Exercise Self-efficacy (EXSE) – Self-efficacy for PA participation was assessed 
using the EXSE scale. It is an 8-item scale that asks subjects to rate the confidence in 
their ability to continue to participate in 40 minutes of continuous moderate exercise 3-
times per week from 1 week to 8 weeks in the future (McAuley, 1993).  The EXSE uses a 
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100-point percentage scale in 10-point increments (0% - not at all confident to 100% - 
completely confident) for each item. Self-efficacy is then calculated by summing the 
ratings and dividing by the total number of items on the scale with a maximum possible 
score of 100 (“Exercise Psychology Lab,” n.d.). The scale was developed to assess 
exercise self-efficacy in older adults but has been validated for use with the MS 
population (McAuley, Motl, White, & Wójcicki, 2010). The scale assesses self-efficacy 
in a longitudinal way, meaning how confident the individual is that they will continue to 
participate in PA over time. 
Markus Self-Efficacy for Physical Activity Scale (MSES) – In addition to the 
EXSE, the MSES was used to assess global self-efficacy for PA in certain common PA 
situations that could be seen as challenging (e.g., when the individual is tired, busy, the 
weather is poor) (Marcus, Selby, Niaura, & Rossi, 1992). The MSES is a 5-item measure 
that is designed to assess an individual’s confidence in ability to continue participating in 
PA in situations that may present challenges. Test-retest reliability has been demonstrated 
at .90 and it has shown adequate internal consistency at .82 (Marcus et al., 1992) 
The combination of these two measures provides a good overall picture of PA 
self-efficacy. The EXSE examines self-efficacy in a longitudinal manner (over 8 weeks) 
could be problematic if an individual experiences regular flare-ups that limit PA at 
certain times. The MSES assesses self-efficacy for PA in global sense and with no time-
line.  
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Quality of Life 
 The Quality of Life (QoL) survey – The Quality of Life Survey (Gill et al., 
2011) is a 32-item Likert-type scale that assesses quality of life with 7 subscales. The 
subscales are integrated (4 items), which reflects overall quality of life, along with social 
(5 items), spiritual (5 items), emotional (5 items), cognitive (5 items), physical (5 items), 
and activities of daily living (ADL)/functional (3 items) quality of life. The scale begins 
with the phrase: “How would you rate the quality of your…” followed by 32 individual 
completers which respondents rate from 1 (poor) to 5 (excellent). Gill et al. (2011) 
developed and then developed the 32-item QoL survey based on a multidimensional, 
positive health conceptual model. Confirmatory factor analyses supported the 
multidimensional structure and all sub-scales had good internal consistency, with alpha 
.76-.95 (Gill et al., 2011). Subsequent research (Gill, Reifsteck, Adams, & Shang, 2015) 
confirmed the factor structure, strong internal consistencies of all sub-scales, and also 
showed good test-retest reliabilities and correlations with matching scales on similar 
measures supporting validity. All 7 subscales will be used in the study. As Gill et al. 
(2015) suggested, the integrated QoL subscale reflects overall quality of life, while the 
other 6 QoL subscales reflect the domains or dimensions of quality of life. The subscales 
that are the most applicable to the current project are physical, functional/ADL, and 
emotional, as well as integrated QoL.  
Satisfaction with Life Scale (SWLS) – The SWLS is a 5-item Likert-type scale 
with respondents reporting from 1 (strongly disagree) to 7 (strongly agree) (Diener et al., 
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1985). The SWLS is a global measure of life satisfaction, which is similar to, and often 
used to measure, overall quality of life. Total satisfaction with life scores range from 5 to 
35. The SWLS was developed from a 48-item self-report scale that included both positive 
and negative items. It was later reduced to 10 items, and after further validation, it was 
reduced to a 5-item single construct scale (Pavot & Diener, 2008). The 5 items have 
shown a strong test-retest correlation. A factor analysis determined that a single factor 
accounted for 66% of the variance, demonstrating a single construct was being tested 
(Diener, Inglehart, & Tay, 2012). As such, the SWLS is an effective measure of global 
satisfaction with life in the current project.  
Open-Ended Items 
Open ended responses – Open-ended questions regarding the participants’ 
experiences with MS, PA, and overall quality of life were included as exploratory 
measures. Questions, which are similar to ones used in the pilot study, are as follows: 
Describe your overall quality of life, How does MS impact your life, What motivates you 
to be physically active, How does physical activity specifically relate to your MS, and 
How does physical activity relate to your overall quality of life? These questions are 
designed to provide added insights by allowing participants to give more detailed 
explanations of the role PA plays in their lives.   
Procedures 
All survey questions were built into an online survey using Qualtrics online 
survey software. After approval was received from the Institutional Review Board, data 
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were collected using the online survey. Participants were recruited from the NMSS 
regional chapters that agreed to distribute the survey by emailing an invitation to 
participate to all MS support group members. The email included a brief description of 
the study, a copy of the informed consent, and a link to the survey. Concurrently, a study 
description with link was placed on the NMSS website research page. Electronic flyers 
were posted in newsletters for regional NMSS chapters, and were distributed via the 
social media website Facebook. Participation was voluntary and no names or identifying 
information were collected on surveys.  
The goal was to collect data from 400 participants, which represents slightly more 
than the 20:1 ratio of participants to variables that is deemed ideal for SEM techniques 
such as path analysis. An acceptable ratio of 10:1 is more often used in SEM due to 
sample size limitations (Kline, 2011). Data collection lasted 42 days in December 2015 
and January 2016.  
Data Preparation and Preliminary Analysis 
 The data were first downloaded from Qualtrics into SPSS Version 23 where data 
were cleaned by removing incomplete responses, confirming individual response format 
was correct for all respondents (e.g., a number of participants wrote out numbers – so 
instead of “2” they wrote “two”), and then calculating individual variable scores for 
survey scales and subscales. Data were also screened at this time for multivariate 
normality. Correlations of all measures were performed to examine all relationships. 
Multiple linear regressions was used to determine the contribution of the individual 
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predictor variables (EXSE, MSSE, QoL, and BREQ-2 subscales) to the relationship of 
self-determined motivation and self-efficacy to PA. Individual sub-scale predictors that 
were not significantly contributing to the relationships in the multiple regression did not 
need to be part of the main path analyses as they do not add information. These variables 
were removed from future analysis.   
Confirmatory Factor Analysis (CFA) was used to test the structure of the BREQ-2 
and QoL measures because measurement issues are very relevant in SEM analysis. CFA 
uses unit loading identifications, by setting a single loading to 1 for the unstandardized 
indicators, to assess overall structure of the scale. Fit indices used to determine fit are the 
chi-square goodness of fit, root mean square error of approximation (RMSEA), 
comparative fit index (CFI), and standardized root mean square residual (SRMS).  The 
chi-square test of overall model fit should ideally not be significant, however chi-square 
is especially sensitive to small sample size which would include this project. For this 
reason the other fit indices were also examined. RMSEA accounts for parsimony in 
model fit. The value should be below .08 with the 90% confidence interval falling below 
.05 (good fit) or .10 (acceptable fit) (Kline, 2011). The CFI tests the proposed model 
against a null model for fit and should be above .90. The SRMR examines the difference 
between observed and estimated correlations and should be below .08 (Kline, 2011). 
Rarely do all fit indices agree on a given model and it has been suggested that as long as 
any two indices indicate good fit the model can be accepted (Hu & Bentler, 1999). When 
model fit was low, individual loadings and model fit indices were examined.  
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Data Analysis 
 The main research questions were addressed using path analysis. The first part of 
the model and research question one, explored the relationship between self-efficacy, 
self-determined motivation, and PA. See Figure 6 for proposed path analysis for research 
question 1. LISREL 8 was used to conduct the path analysis.  Path analysis is part of the 
family of SEM, which is a method of describing causal relationships among endogenous 
and exogenous variables (Vogt & Johnson, 2011). Path analysis simultaneously examines 
the strength of causal relationship in an overall theorized model. For research question 1, 
the model was specified as initially proposed in accordance with SDT, and all fit indices 
(chi-square, RMSEA, CFI, SRMR) were examined for goodness of fit. The individual 
unstandardized path loadings of the proposed model were examined for fit. Where poor 
model fit was indicated, respecification in accordance with existing theory was 
performed.  It is important in path analysis that all respecification is driven by theoretical 
background in order to insure the results remain within the scope of the research question 
(Kline, 2011). 
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Figure 6. Proposed Path Model of Self-Determination, Self-Efficacy, and PA 
 
 
Research question 2 focused on the relationship between PA and quality of life.  
Path analysis was again used to model the relationship between all QoL subscales and PA 
(see figure 7).  Respecification was performed as necessary in the same manner as with 
research question 1. A separate model examined the 6 QoL subscales (physical, 
emotional, ADL/functional, cognitive, social, and spiritual) as predictors of the QoL 
Integrated mode to determine if the QoL measure should be included in the final model 
as a single construct or as multiple constructs. It was hypothesized that at least some of 
the individual QoL constructs and integrated QoL contribute to the model. See Figure 8 
for representations of this model.  
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Figure 7. Path Model of PA – QoL Subscales  
 
 
 
Figure 8. Path Model of the Multidimensional QoL Relationships 
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After the separate parts of the model from research questions 1 and 2 were 
examined, an overall path model was examined. This overall model includes the paths 
from self-determined motivation and self-efficacy to PA participation, and from PA to 
QoL. It was examined in the same way as the previous models and was respecified using 
logical, theoretical background as guidance. The proposed overall model is shown in 
Figure 9. During the examination of the overall model, Sobel’s Test of Mediation was 
used to examination if the partial mediation between variables was significant (Sobel, 
1982). This test specifically examines mediation in path analysis models.  
 
 
Figure 9. Path of Overall Model 
 
 
After the final overall model was respecified and confirmed, the model was run 
separately for low (PDDS 0-3) and high (PDDS 4-8) disease step groups, to see if the 
 
PA 
Amotivation 
External 
Regulation 
Internalized 
Regulation 
Identified 
Regulation 
Intrinsic 
Motivation 
Self-Efficacy QoL Social 
QoL Spiritual 
QoL Cognitive 
QoL Physical 
QoL ADL  
QoL Emotional 
QoL Integrated 
 
 
 
52 
 
 
models were equivalent across disability levels. This addressed research question 3.   
Crosstabs of PDDS and PA levels were also examined. In the examination of research 
question three, Chi-Square test of difference was also used to examine the relationship 
between the PA level and PDDS to give a better idea of the linear nature of the 
relationship. 
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CHAPTER IV 
RESULTS 
 
 
 The purpose of this study was to explore the relationships among self-determined 
motivation, self-efficacy, PA participation, and quality of life in individuals with MS. 
This chapter reports basic demographics and relationships and then focuses on the results 
of the path analyses used to explore the research questions. 
Sample Demographics 
The sample consisted of 215 individuals between the ages of 18 and 65 years who 
had been diagnosed with MS at least one year prior to participation. The survey link 
collected 305 total responses; a response was categorized by Qualtrics as any individual 
who clicked on the survey link that took them to the informed consent and study 
description. Of the 305 responses, 50 were removed because they did not answer any 
questions and exited out of the survey without progressing past the informed consent and 
study description. The remaining 255 participated in at least a portion of the survey. The 
remaining dataset was still above the 10:1 ratio suggested by Kline (2011) so a decision 
was made not to include incomplete data (see Table 3). During the preliminary 
examination of results, 2 additional responses were removed because they did not report 
having MS, and 2 participants were removed because they were outside the specified age 
range, reporting ages of 73 and 80 years old. Both of these individuals were white males,
 
 
 
54 
 
both had advanced progression of MS and both reported no PA participation (Table 3). 
The 215 remaining responses were used in the analysis of the research questions. 
Respondents had a mean age of 48.9 years (SD = 9.4), with an average time with MS of 
11.96 years (SD = 8.28), were 80% female (n = 172) and 20% male (n = 43), and were 
predominantly white (n = 197). 
 
Table 3. Explanation of Survey Dropout and Final Sample  
Participants  Survey section 
305 Initial survey link 
Dropout – last section completed 
50 Informed Consent 
9 SDS 
10 BREQ-2 
1 PA type 
11 ESSE 
3 QoL 
2 PDDS 
219 Complete 
4 Did not meet inclusion criteria  
215  Total Participants 
 
 
Due to the variability of MS, information was collected about the participants’ 
current stage of MS (PDDS), flare up history, PA level currently and prior to diagnosis, 
and most common symptoms (tables 4 to 6). Participants reported PDDS scores across 
the range of the measure with 65.1% of participants reporting PDDS scores of 0-3 (not 
requiring mobility assistance) and 35.9% reporting PDDS scores of 4-7 (requiring some 
type of mobility assistance). No participants reported a PDDS score of 8 (bedridden) 
(Table 4; see Appendix A for a complete description of PDDS levels). A majority (67%) 
of participants reported 1 or fewer flare-ups per year and only 5.6 % indicated more than 
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9 flare-ups per year (Table 5). Almost half of participants (47.4%) had not experienced a 
flare-up in the past year. A small percentage (12.6%) had experienced a flare-up less than 
1 month ago. No patients reported currently being in a flare-up (Table 5). PA levels 
before MS were high in this sample, with 87% of respondents reporting that they were 
physically active before they were diagnosed with MS. Almost two-thirds of respondents 
(62.3%) reported currently participating in some type of PA, duration and intensity not 
specified. An examination of the Godin PA data (which looks at moderate to vigorous 
intensity PA) reflected these self-report assessments of activity level, with 55.3% 
classified as insufficiently active, and 44.7% active (Table 6). When classified into 
defined activity (e.g., METs as specified by the Godin PA measure), PA levels reported 
by some individuals did not meet the guidelines and therefore although individuals 
reported were active, they were not sufficiently active to be classified as such by the 
Godin. This explains the discrepancy between the two current PA reported numbers. 
 
Table 4. Participant PDDS Scores 
PDDS Score Frequency Percentage 
0 56 26.0 
1 29 13.5 
2 23 10.7 
3 32 14.9 
4 25 11.6 
5 18 8.4 
6 19 8.8 
7 13 6.0 
8 0 0 
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Table 5. Participant MS Flare-Ups per Year and Time Since Last Flare-Up 
Number of Flare-ups Frequency Percentage 
1 or less per year 144 67 
2-3 per year 47 21.9 
4-6 per year 12 5.6 
9 or more per year 12 5.6 
Time Since Last Flare-up Frequency Percentage 
Less than 1 month ago 27 12.6 
1-2 months ago 16 7.4 
3-4 months ago 27 12.6 
5-6 months ago 18 8.4 
7-9 months ago 10 4.7 
10-12 months ago 15 7.0 
More than 12 months ago 102 47.4 
 
 
Table 6. Self-Report PA before MS Diagnosis, PA Currently, and Godin PA Level 
Physically Active before 
MS? 
Frequency Percentage 
Yes 187 87 
No 28 13 
Physically Active 
currently? 
Frequency Percentage 
Yes 134 62.3 
No 81 37.7 
Godin PA Frequency Percentage 
≤ 23 insufficiently active 119 55.3 
≥ 24 active 96 44.7 
 
 
 Participants reported a wide variety of symptoms as a result of MS and most 
reported multiple symptoms (Table 7). The most common symptom, fatigue, was 
reported by 50.7% of participants, and almost half (45.6%) reported 
gait/coordination/muscle weakness as a symptom. Most symptoms related to physical 
functioning. The only other reported symptom was emotional disturbances/depression 
(7% of participants). Only one participant reported not experiencing symptoms.  
 
 
 
57 
 
Table 7. Most Common MS Symptoms Experienced by Participants 
Symptoms Frequency* Percentage 
Fatigue 109 50.7 
Gait/Coordination/Muscle Weakness 98 45.6 
Neuropathy/Numbness/Tingling/Burning/Itching 73 34.0 
Cognitive/Brain Fog/Memory Issues 66 30.7 
Vertigo/Dizziness/Balance 43 20.0 
Vision Problems 39 18.1 
Pain 35 16.3 
Bladder/Bowel 33 15.3 
Stiffness/Spasticity/Cramping 27 12.6 
Emotional Disturbances/Depression 15 7.0 
Heat Intolerance 8 3.7 
Insomnia 6 2.8 
Speech Problems 6 2.8 
Headache 6 2.8 
Breathing/Swallowing Difficulties 4 2.0 
MS Hug (tightness in chest cavity) 4 2.0 
Sexual Dysfunction 2 1.0 
Tremors 2 1.0 
Seizures 2 1.0 
Ringing in Ears 1 0.4 
Stomach/ Digestive Issues 1 0.4 
Weight Loss 1 0.4 
Dysautonomia 1 0.4 
Increased Blood Pressure/Heart Rate 1 0.4 
None 1 0.4 
* Most participants reported more than one symptom  
 
 
Preliminary Analyses 
 Prescreening indicated the data were roughly normally distributed, with very little 
skew and kurtosis, pointing to multivariate normality among the data and meeting the 
assumption of multivariate normality. This is important because in maximum likelihood 
estimation, it is essential to obtaining a well-fitting model (Kline, 2011). Confirmatory 
Factor Analysis was used to examine the factor structure of the BREQ-2 and QoL scales. 
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Four indices of model fit were used to assess goodness of fit (Chi-square, RMSEA, CFI, 
SRMR) and fit was determined to be good if any two fit indices demonstrated a well-
fitting model (Hu & Bentler, 1999).  
The BREQ-2 was modeled with all 5 subscales and the result demonstrated poor 
fit, χ2(5) = 75.12, p <.01; RMSEA = .255 (90% Confidence interval .21 - .47); CFI = 
.070; SRMR = .128. An examination of the literature on the development of the BREQ-2 
scale reveals the Amotivation subscale demonstrated some reliability issues due to range 
limitations. Researchers decided to include it in the measure but suggested further 
validation (Markland & Tobin, 2004). Consequently, the BREQ-2 was run without the 
Amotivation subscale and the 4 remaining subscales and produced a model that 
demonstrated very good fit, χ2(4) = 2.71, p = .257; RMSEA = .041 (90% Confidence 
interval .00 - .15); CFI = .099; SRMR = .039.   
CFA was also used to assess the factor structure of the QoL scale. Results using 
all 7 subscales indicated acceptable fit, χ2(7) = 120.6, p < .01; RMSEA = .120 (90% 
Confidence interval .11 - .22); CFI = .090; SRMR = .050.  
Reliability of all scales or subscales was examined and all were deemed reliable, 
see Table 8. The BREQ-2 External Regulation subscale with a Cronbach’s Alpha of .653 
is still above .60, which is considered the acceptable cut-off point for reliability measures 
(Cronbach, 1951). 
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Table 8. Reliability of All Measures 
Measure Cronbach’s 
Alpha (α) 
QoL Social .905 
QoL Spiritual .950 
QoL Emotional .937 
QoL Cognitive .915 
QoL Physical .825 
QoL ADL .896 
QoL Integrated .943 
SWLS .918 
SDS .863 
EXSE .995 
MSES .800 
BREQ-2 Amotivation .878 
BREQ-2 External Regulation .653 
BREQ-2 Introjected Regulation .777 
BREQ-2 Identified Regulation .852 
BREQ-2 Intrinsic Motivation .936 
 
 
Correlational analysis of all variables revealed a number of significant 
relationships (see Appendix C for the full correlation matrix). As expected both self-
efficacy scales showed a significant relationship with Godin PA level (EXSE, r = .48; 
MSES, r = .43) (see Table 9).  The BREQ-2 subscales of intrinsic motivation (r = .24) 
and identified regulation (r = .40) were positively correlated with Godin PA level (see 
Table 10). SWLS was significantly positively correlated to all QoL subscales with the 
highest correlation being between SWLS and Integrated QoL (r = .81) (see table 11). 
Godin PA level had a significant relationship with Social QoL (r = .22), Emotional QoL 
(r = .20), Cognitive QoL (r = .22), Physical QoL (r = .47), ADL QoL (r = .35), and 
Integrated QoL (r = .26) (see table 11).   
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Table 9. Correlation of All Self-Efficacy Measures and PA 
  1 2 3 
1 EXSE 1   
2 MSES .27** 1  
3 PA Level .48** .43** 1 
* significant at p < .05; ** significant at p < .01 
 
 
Table 10. Correlation of All Self-Determination Measures and PA 
  1 2 3 4 5 6 7 
1 SDS 1       
2 Amotivation -.37** 1      
3 External -.21** .33** 1     
4 Introjected -.13 -.18** .28** 1    
5 Identified .24** -.62** -.16* .45** 1   
6 Intrinsic .59** -.26** -.03 -.11 .18* 1  
7 PA Level .21** -.28** -.19** .12 .40** .24** 1 
* significant at p < .05; ** significant at p < .01 
 
Table 11. Correlation of All QoL Measures and PA 
  1 2 3 4 5 6 7 8 9 
1 PA Level 1         
2 Social QoL .22** 1        
3 Spiritual QoL .04 .50** 1       
4 Emotional QoL .20** .75** .53** 1      
5 Cognitive QoL .22** .53** .34** .54** 1     
6 Physical QoL .47** .53** .25** .50** .49** 1    
7 ADL QoL .35** .51** .26** .49** .43** .69** 1   
8 Integrated QoL .26** .80** .44** .88** .56** .63** .65** 1  
9 SWLS .31** .72** .38** .72** .48** .61** .64** .81** 1 
* significant at p < .05; ** significant at p < .01 
 
 
Due to the high multicollinearity among some of the subscale variables, steps 
were taken to eliminate variables that were not contributing to the relationships of 
interest. Previous research (Gill et al., 2015) indicates that SWLS is a reflection of overall 
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quality of life and in conjunction with the high correlation between it and the integrated 
QoL subscale (r = .81), removal from future analyses was warranted. 
Two sets of multiple regression analyses were performed to examine the relative 
contribution of variables. The self-efficacy variables (EXSE and MSES) and all self-
determination variables (BREQ-2 scales of Amotivation, Extrinsic Regulation, 
Introjected Regulation, Identified Regulation, Intrinsic Motivation; and the SDS) were 
examined in relation to PA to determine if some variables could be removed prior to path 
analysis. A multiple regression of the EXSE and MSES as predictors of PA resulted in an 
R2 = .26 F(2, 212) = 37.46, p <.001. Examination of the Beta weights of this regression 
indicated that the MSES contributed very little above the contribution of the EXSE (see 
table 12). This was confirmed by simple regression on each variable, when regressed on 
PA, EXSE resulted in an R2 = .23 F(1, 213) = 62.46, p <.001 and MSES resulted in an R2 
= .09 F(1, 213) = 23.18, p <.001. The addition of the MSES, although statistically 
significant, appears to be practically unimportant as it adds very little to the R2 change, 
therefore path analyses use only the EXSE.  
The multiple regression model with all five predictors BREQ-2 scores as 
predictors of PA produced R² = .203, F(5, 209) = 10.64, p < .001.  The Identified 
Regulation and Intrinsic Motivation scales had significant positive regression weights and 
the External Regulation scale had a significant negative regression weight (see Table 13). 
The Amotivation and Introjected Regulation scales did not contribute to the multiple 
regression model and were removed. The revised model produced R2 = .201 F(3, 211) = 
17.70, p <.001. The SDS measure was then added to this model (R2 = .201 F(4, 210) = 
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13.21, p <.001). The SDS score did not contribute significantly and was not included in 
path analyses.  
 
Table 12. Standardized Regression Coefficients of Self-Efficacy Variables 
 Beta t p value  
EXSE .345 4.773 .001 
MSSE .227 3.140 .002 
F 37.458 (2, 212); R2 change = .261 
 
 
Table 13. Standardized Regression Coefficients of BREQ-2 Variables 
 Beta t p value 
Amotivation .049 .579 .563 
External Regulation -.149 -2.090 .038 
Introjected Regulation .033 .422 .674 
Identified Regulation .356 3.989 .001 
Intrinsic Motivation .184 2.791 .006 
SDS .017 .206 .837 
F 8.835 (6,208); R2 change = .203 
 
 
Main Analyses 
 Prior to performing the main analyses, it was important for the preliminary 
analyses to remove extraneous variables and confirm factor structure of the measures. 
Accuracy of analysis depends on good factor structure of measures and variables that are 
not highly related but contribute to the relationships being examined (Kline, 2011). Once 
completed, the main research questions could be examined. Research question one 
explored the relationship between self-determined motivation, self-efficacy for PA, and 
PA levels in people with MS.  Based on preliminary analysis the extraneous self-efficacy 
scale (MSES) and overall self-determination scale (SDS) were removed from the 
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analyses. Preliminary analysis also led to the removal of Amotivation and Introjected 
Regulation from the analysis. The path model with EXSE, BREQ-2 External Regulation, 
BREQ-2 Identified Regulation, and BREQ-2 Intrinsic motivation was examined. Because 
the four exogenous variables (EXSE, BREQ-2 External Regulation, BREQ-2 Identified 
Regulation, and BRE-2 Intrinsic motivation) were predicting the single endogenous 
variable (PA) the model fit was just identified (df  = 0) and therefore all fit indices 
indicated perfect fit. In this case, the parameter estimates are examined to determine if all 
exogenous variables have significant direct effects on the endogenous variable. 
Respecification of a model must be done with theoretical consideration to avoid simply 
capitalizing on chance (Kline, 2011). If removal of parameters and the resulting model do 
not make theoretical sense, statistical significance is unimportant. Path analysis relies on 
firm theoretical background to support the model otherwise it is possible that statistical 
chance is driving results (Kline, 2011). External Regulation and Intrinsic Motivation did 
not have significant effects and with no theoretical justification for keeping them, they 
were removed from the model. See Table 14 for path coefficients, standardized estimates, 
and significance. In the model with the remaining exogenous variables (EXSE and 
Identified Regulation), both had significant direct effects on PA and this model was 
retained. See Table 14 and Figure 10.  
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Table 14. Parameter Estimates for Self-Efficacy, Self-Determination and PA 
Parameter Unstandardized SE Standardized 
Model 1    
EXSE .207* .045 .330 
External Regulation -3.010 1.759 -.101 
Identified Regulation 4.155* 1.622 .179 
Intrinsic Motivation 3.214 1.863 .105 
Model 2    
EXSE .232* .044 .370 
Identified Regulation 4.457* 1.637 .192 
* Significant at p < .05 
 
 
EXSE_TOT = Total EXSE score; BREQ_IDE = Identified Regulation; GODIN_PA = PA Level 
Figure 10. Final Path Diagram of EXSE, Identified Regulation, and PA 
 
 
 Research question two examines the relationship between PA participation and 
quality of life. The expectation is that individuals with MS who are more physically 
active have higher perceived quality of life. The research question is explored first with 
overall quality of life (using the QoL Integrated scale) and then with quality of life as a 
multi-dimensional construct (using the QoL scales of social, spiritual, emotional, 
cognitive, physical, and ADL). For the first part of the question, the regression analysis 
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showed a significant positive relationship, R2 = .224 F(1, 213) = 20.314, p <.001.  The 
second part of the research explored the relationship between PA and the QoL subscales. 
Various renditions of the paths between PA and the QoL subscales all demonstrated poor 
fit (see Table 15), most likely due to the high multicollinearity among the scales. Recent 
research supports using the QoL Integrated scale as an overall measure of QoL, with the 
other subscales loading onto the Integrated scale (Gill et al., 2015). For this reason the 
relationship of the QoL subscales as predictors of Integrated QoL was examined. The 
first model, using all QoL subscales (social, spiritual, emotional, cognitive, physical, 
ADL) as exogenous variables and QoL Integrated as the endogenous variable, 
demonstrated that all parameters except QoL Cognitive showed significant direct effects. 
The model was run again without the QoL Cognitive variable and all parameters were 
significant predictors of Integrated QoL (figure 11). See Table 16 for all path 
coefficients, standardized estimates, and significance for the modified model.  
 
Table 15. Fit Indices of the Main Models Testing PA and QoL Scales 
 Model 1 Model 2 Model 3 Model 4 
χ2(p=) 953.79 (p<.001) 242.69 (p<.001) 456.26 (p<.001) 291.39 (p<.001) 
df 21 3 11 7 
RMSEA .455 .610 .434 .435 
CFI .113 .280 .542 .675 
SRMR .382 .292 .389 .265 
Model 1: PA and all QoL scales; Model 2: PA and QoL Physical, ADL, Integrated, Model 3: PA, all QoL 
subscales, QoL subscales and QoL Integrated; Model 4: PA as predictor of QoL Physical, ADL, 
Emotional, Social and subscales as predictors of QoL Integrated. Other models were also tested but these 
produced the best fit. All are poorly fit models. 
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Table 16. Parameter Estimates for QoL Subscales and QoL Integrated 
Parameter Unstandardized SE Standardized 
Model 1    
Social .213* .034 .255 
Spiritual -.050* .023 -.066 
Emotional  .454* .032 .579 
Cognitive .003 .026 .003 
Physical .076* .031 .091 
ADL .225* .042 .191 
Model 2    
Social .213* .034 .256 
Spiritual -.050* .023 -.066 
Emotional .455* .032 .579 
Physical .077* .030 .092 
ADL .225* .042 .191 
* Significant at p < .05  
 
 
 
QOL_SOC = Social QoL; QOL_SPIR = Spiritual QoL, QOL_EMOT = Emotional QoL; QOL_PHYS = 
Physical QoL; QOL_ADL = Functional/ADL QoL; QOL_INTE = Integrated QoL 
Figure 11. Path Diagram of QoL Subscale Relationship to QoL Integrated 
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 The goal of this project was to combine research questions 1 and 2 and examine a 
model of the relationships among self-efficacy for PA, self-determined motivation for 
PA, PA participation, and quality of life. Based on the resulting models for both halves of 
the proposed overall model, the main model was tested using path analysis. The model 
included EXSE and BREQ Identified, PA, and QoL integrated (see figure 12). This 
model resulted in poor to marginal fit, χ2(2)= 8.65; RMSEA = .124; SRMR = .06, CFI = 
.958.  
 
EXSE_TOT = Total EXSE score; BREQ_IDE = Identified Regulation; GODIN_PA = PA Level; 
QOL_INTE = Integrated QoL 
 
Figure 12. Path Model of Original Proposed Overall Relationships 
 
 
Although not included in the original overall model, there is evidence that self-
efficacy directly influences quality of life in individuals with MS (Motl & McAuley, 
2009); and although there is no research  on the relationship between self-determination 
and quality of life, self-determination and self-efficacy are related constructs (Sweet et 
al., 2012). Therefore, the relationship between self-efficacy and quality of life, and the 
relationships between self-determination and quality of life were independently examined 
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to improve model fit. Two respecified path models were examined, one included the 
direct path from EXSE to QoL Integrated, and the other a direct path from BREQ 
Identified to QoL Integrated. Both models demonstrated good fit, see table 17. Based on 
previous research that supports self-efficacy as a determinant of quality of life (Motl & 
McAuley, 2009), and modification indices from the original model indicating an addition 
of a path from EXSE to Identified QoL would decrease 𝜒𝐷
2(1) by 8.4, model 2 was 
retained (table 17; figure 13). The mediating effect of PA between EXSE and QoL 
Integrated was examined using Sobel Test of  Mediation (“Interactive Mediation Tests,” 
n.d.; Sobel, 1982). Results indicated a significant mediating effect (t = 1.977; p <.05). 
 
Table 17. Fit Indices for the Overall Model 
 Model 1 Model 2 Model 3 
χ2(p=) 8.65 (p=.013) .02 (p=.867) 6.56 (p=.010) 
df 2 1 1 
RMSEA .124 .000 .161 
CFI .958 1.0 .965 
SRMR .060 .002 .041 
Model 1: Original model of EXSE, BREQ Identified  PA  QoL; Model 2: Added direct effect from 
EXSE to QoL; Model 3: Added a direct effect from BREQ Identified to QoL. 
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EXSE_TOT = Total EXSE score; BREQ_IDE = Identified Regulation; GODIN_PA = PA Level; 
QOL_INTE = Integrated QoL 
 
Figure 13. Final Respecified Overall Model  
 
 
 Research question three explored the relation of disease step to PA participation. 
The first part of the question determine whether higher disease step related to lower PA 
participation and quality of life. Analysis of Variance was used to assess differences in 
PA participation between individuals reporting low-disease step (PDDS 0-3; n = 108) and 
individuals reporting high disease step (PDDS 4-8; n = 107), see Table 18 for means and 
SD. The cut point corresponds with the ability to walk more than 25 feet unaided and 
where previous research has found a distinction in PA behavior (Klaren et al., 2013). 
Results indicated a significant difference in PA participation between groups, F(1, 213) = 
20.17, p <.001. Crosstabs using Chi-Square also reflected this, χ2 = 18.74, p < .001. See 
Table 19 and Figure 14. 
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Table 18. Means and SD for PDDS and PA Levels 
 Mean (SD) Godin Mean (SD) Range 
PDDS 0 – 3  1.7 (.80) 33.71 (29.40) 0 – 173  
PDDS 4 – 8  5.58 (1.39) 18.65 (18.75) 0 – 102  
 
 
 
 
Figure 14. Relationship Between PA Level and PDDS 
 
 
Table 19. Crosstabs of PA Level and PDDS 
 PDDS 0-3 PDDS 4-8 Total 
Godin Inactive  44 75 119 
Godin Active 64 32 96 
Total 108 107 215 
PDDS 0-3 
PDDS 4-8 
Godin 
Active 
Godin 
Inactive 
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The second part of research question 3 examined the overall model in relation to 
disease step to see if the model was equivalent between individuals with low or high 
disease step. The model was run with each of the two groups and all fit indices indicated 
a well-fitting model. There was no difference in the model fit. See table 19 for fit indices 
for both models.  
 
Table 20. Fit Indices for Low Disease Step and High Disease Step Models 
 
 PDDS 0-3 
n = 108 
PDDS 4-8 
n = 107 
χ2(p=) .32 (p=.57) 2.74 (p=.39) 
df 1 1 
RMSEA .001 .001 
CFI 1.0 1.0 
SRMR .012 .022 
 
 
Open-Ended Responses 
 Responses to the 5 open-ended questions were first read by two separate 
researchers and discussed until basic themes were agreed upon, as is acceptable protocol 
for consensus coding (Creswell, 2013). The agreed-upon themes were in line with the 
research questions. Each researcher individually coded the data and then compared 
coding. If discrepancies existed the two discussed the statement until a code could be 
agreed upon (Creswell, 2013). After codes were agreed upon, individual responses were 
counted to determine the number that corresponded with each code. These totals are 
presented in tables 21 – 25. 
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Describe Your Overall Quality of Life  
Approximately two-thirds of participants described their quality of life as 
positive. “My quality of life is excellent.” Many of these participants reported the 
occasional bad day due to MS symptoms but still reported overall good quality of life. “In 
spite of physical limitations, I have a great quality of life.  I am active and that's 
important to me.  I do not drive but my husband drives me and participates in most of my 
activities.  We go to the gym together but we each do our separate workouts.” A smaller 
portion of participants reported declining or poor quality of life. Those who reported poor 
quality of life cited MS symptoms as the cause. ” I feel like I don't even have a quality of 
life, if I do, it is so low because I can't do the things I used to enjoy.” This sentiment was 
echoed by those who cited low quality of life. A summary of responses and percentage of 
respondents can be seen in Table 21.  
 
Table 21. Overall Quality Of Life of Participants 
Theme/Description Number of 
Participants 
Percentage 
of total 
Excellent/MS has little or no impact, I am happy with 
how my life is 
81 45.8 
Good days and bad days, some limitations but mostly 
positive quality of life 
43 24.3 
Quality of life is okay but there are 
limitations/challenges, MS definitely impacts it, neither 
good nor bad 
21 11.9 
Quality of life is Declining, MS impacts ability and 
overall quality of life on regular basis 
18 10.2 
Quality of life is poor, there is severe MS impact, 
feelings of isolation, desperation 
14 7.9 
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How Does MS Impact Your Overall Quality of Life?  
This question prompted more than one response from a number of participants. 
Many discussed physical and/or cognitive symptoms that limited the ability to live a 
normal life and the impact that had on their overall quality of life. “MS impacts me 
mostly from cognitive issues which all but paralyzes me at times.  It is hard to 
communicate when you can't talk.” Others indicated that MS symptoms sometimes 
affected their lifestyle but did not affect their quality of life. “I don't think my MS has had 
an impact on my overall quality of life.  I just work around the few mild symptoms that I 
do have.” Some respondents indicated that MS had no impact whatsoever on their lives 
“It doesn’t”, “Minimally”, and “Not at all” were reported by this group of participants. 
For a summary of responses see Table 22. 
 
Table 22. Impact of MS on Overall Quality Of Life of Participants 
 
Theme/Description Number of 
Participants 
Percentage 
of total* 
None. MS does not impact QOL 27 15.3 
MS has some impact on life but positive outlook and 
good QOL in spite of symptoms 
25 14.1 
MS limits physical ability, causes fatigue, decreases 
QOL in some way 
66 37.3 
MS limits cognitive functioning, emotion strain, 
increased depression 
18 10.1 
MS limits job abilities, employment status, activities, 
social abilities 
26 14.7 
MS general limits all aspects of QOL, QOL is poor 
due to MS 
40 22.6 
* Percentages total more than 100% because some responses listed more than one impact; for example, 
many individuals cited both physical challenges and cognitive difficulties. 
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What Motivates You to be Physically Active (If You Are)?   
This question directly asks about the motivation for PA participation. The results 
were in line with SDT.  A small number of participants reported no motivation for PA 
participation (amotivation). “Nothing” and “Not very” were typical of these short 
responses. A number of participants reported being active for others (introjected 
regulation). “For my grandkids”, “My girlfriend motivates me to be healthy”, and even 
“My dog is a motivator. I've had her for 15 years, purposefully to keep me moving even 
if I was too tired.” For these individuals, they are motivated by the obligation to be 
healthy for the people (or animals) in their lives. A majority of participants reported some 
type of disease symptom control, physical benefit, health and wellness, or just generally 
to beat MS as the reason they were physically active (identified regulation). “I can 
control my cognitive symptom of MS better when I am physically active”, “I work out to 
keep my muscles strong. I feel that if I keep them strong, I can control them better”, and 
“I know swimming and strength training have made a huge impact on my MS symptoms. 
My gait and overall quality of life improved” are representative of the responses given. A 
number of participants reported participating in PA for the enjoyment of the activity 
(intrinsic motivation). “Because I love it” and “enjoyment” were the types of responses 
these individuals gave. Self-efficacy was also a theme throughout the responses. 
“Because I can” was a sentiment that was cited by more than one participant. A summary 
of responses can be found in Table 23. 
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Table 23. Motivation for PA Participation 
 Theme/Description Number of 
Participants 
Percentage 
of total* 
Control physical MS symptoms 28 16 
Control cognitive MS symptoms 2 1.1 
Stress Management 2 1.1 
Others (family, friends, health care professionals, 
dog)  
42 24 
Accomplishment, Identity, Because I can 8 4.6 
Overall health, weight loss, increased strength 48 27.4 
Enjoyment, feel better/good, increased mood 37 21.1 
Physical appearance, to look good 7 4 
Nothing, not motivated, can’t do PA 23 13.1 
To beat MS 11 6.3 
* Percentages total more than 100% because some responses listed more than one impact; for example, 
many individuals cited being active for their families and to feel better. 
 
 
How Does PA Specifically Relate to Your MS?  
Many participants reported physical and/or psychological benefits and symptom 
management as a result of this relationship. “It helps manage stress which in turn helps 
manage my MS”, “The less I move the more spasticity I endure in my shoulders, arms, 
neck, hips and calves” and “I believe that physical activity is key to those that are living 
with MS.  Muscle atrophy is a symptom that I experienced in my legs.  I was able to 
slowly get strength back by being consistent over time with my workouts.” Other 
participants reported physical weakness or pain as a result of PA. “Fatigue, fatigue, 
fatigue.” And “Makes me pass out” are representative of the answers in this theme. Many 
of these participants reported continuing with PA because of the long-term physical 
benefits they saw even if the immediate result was negative. “Overall it helps but it is 
hard to stick it out sometimes because of the pain” and “It is more difficult to exercise 
because heat triggers symptoms but it is worth it” were ways that this relationship got 
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explained. A small number of participants reported no relationship or no desire or ability 
to participate in PA. For a summary of all responses see Table 24.  
 
Table 24. Specific Ways PA Relates to the Individual’s MS 
Theme/Description Number of 
Participants 
Percentage 
of total  
Move it or lose it, controls symptoms, disease 
management 
53 30.6 
Manage stress 2 1.1 
Negative impact of PA, pain, fatigue, increased 
symptoms 
32 18.5 
Not able to be physically active 5 2.9 
Increases mental state, emotional wellness, self-
confidence, generally make me feel good 
7 4 
PA for general health and well-being, strength 11 6.4 
Limited ability to do PA, Less PA than before MS 34 19.7 
PA and MS related but undefined by response 15 8.7 
Not related. MS does not impact PA levels 12 6.9 
N/A. Not physically active, don’t want to be 7 4 
* Percentages total more than 100% because some responses listed more than one impact; for example, 
many individuals cited both long-term physical benefits and fatigue immediately post-exercise.  
 
 
How Does PA Make You Feel?  
This question prompted participants to talk about the positive and negative 
outcomes of PA participation. Both physical and psychological benefits were included. 
Many participants simply responded “good” or “excellent” in response to the question. 
Others elaborated on the positive feelings elicited, for example one participant said “It's 
always hard to get to the gym, but after my workouts I feel happy and like I achieved a 
big goal”. The most common negative responses were pain and fatigue related issues. 
“Extremely fatigued”, “HOT and sometimes that increases my fatigue”, and “Sore, tired, 
painful some days” were typical response from participants with this theme. Some 
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participants acknowledged both positive and negative outcomes. “Physical activity makes 
me feel great mentally but exhausted physically.” For this individual, the benefits from 
PA are recognized and a reason to continue participating but the negatives also contribute 
to the decision to participate. For a complete summary of all responses and percentages 
see Table 25.  
 
Table 25. Positive and Negative Outcomes to PA Participation 
Theme/Description Number of 
Participants 
Percentage 
of total  
Negative PA outcomes   
Pain, muscle soreness, physical issues, added 
limitations 
10 5.7 
Tired, fatigue, no energy 58 33.1 
Overheated, hot, heat problems 2 1.1 
Anxious, depressed, sad, frustrated 6 3.4 
Positive PA outcomes   
Positive emotional responses – confident, 
accomplished, enjoyment, happy, etc. 
110 62.9 
Cognitive improvements, thinking better 4 2.3 
Physical improvements, strong, healthy 20 11.4 
More energy, energized, full of life 5 2.9 
N/A   
            Explicitly stated that they cannot/do not exercise 7 4 
* Percentages total more than 100% because some responses listed more than one impact; for example, 
many individuals cited both positive emotional response and fatigue.  
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CHAPTER V 
DISCUSSION 
 
 
The purpose of this project was to examine the relationships among self-efficacy, 
self-determined motivation, PA and quality of life. First, self-efficacy, self-determined 
motivation for PA, and global self-determination were examined in relation to PA 
participation. Following that, PA was examined as a predictor of multidimensional 
domains of quality of life (social, spiritual, cognitive, emotional, ADL/functional, and 
physical) and as a predictor of overall quality of life. Finally, a path model of the 
relationships was developed with self-efficacy and self-determination predictors of PA 
and PA predicting quality of life. This model was also examined to determine whether 
the model was consistent for individuals at different disease levels of MS.  
The first research question addressed the relationship of self-efficacy and self-
determined motivation with PA. The expectation was that self-efficacy and the more 
internalized forms of self-determination (intrinsic motivation, identified regulation) 
would positively predict PA. This question was addressed first by a preliminary 
correlational analysis, and then through path analysis. The final path model indicated that 
only self-efficacy and identified regulation were predictors of PA participation. Self-
efficacy is the individual’s belief that they can successfully engage in an activity, in this 
case, PA. The relationship between self-efficacy and PA in the MS population has been 
seen in past research, and this result was expected (Motl & Snook, 2008). Self-efficacy 
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was a stronger predictor of PA behavior than identified regulation and self-efficacy had 
both a direct and an indirect effect (through PA) on quality of life. There is evidence that 
self-efficacy is an integral part of the self-determination constructs of competency and 
autonomy in PA settings (Sweet et al., 2012). This could explain why it was a stronger 
predictor of PA participation in the current model.  
The more interesting part of this model is the addition of identified regulation. 
Identified regulation is the motivation to participate in an activity for the outcomes the 
activity provides (Deci & Ryan, 2004). In a physical activity scenario, these outcomes 
have been reported as fitness, health, and better body physique (Frederick-Recascino & 
Schuster-Smith, 2003). For the MS population this suggests that motivation for PA 
participation is partly predicted by the physical benefits in the form of disease 
management that participants perceived PA provided. Confirmation of this was reported 
by many participants in the open-ended responses. For example, “Must. Keep. Moving. If 
I don't use it I'll lose it”, “It (PA) keeps me limber, lessens the pain a bit and helps 
tremendously with balance”, “I want to keep the abilities I still have”, and “Without it 
(PA), I would physically be in much worse condition”. These statements reinforce the 
path model results. Clearly, identified regulation is important to the MS population, 
presumably because physical benefits in disease management are so crucial.  
 During the development of this model, decisions had to be made about the 
practical and theoretical importance of including and removing factors. If model 
respecification is driven only by statistics and not supported by theory it is possible to 
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develop a model with good fit that is a result of statistical probability (Kline, 2011). The 
first model of research question 1 included the BREQ-2 scales of external regulation and 
intrinsic motivation. These two scales did not significantly contribute to the model.  
Removal of the factors was done only after consideration of the overall implications. 
External regulation is behavior motivation that is driven by external rewards, in a PA 
setting an example is motivation to participate to win, as often seen in athletes (Medic, 
Mack, Wilson, & Starkes, 2007). A more appropriate example for this population would 
be because a doctor or health care professional orders PA, but this usually comes in the 
form of a recommendation, not an order. For individuals with a chronic, degenerative 
disease such as MS, the “win” does not seem a relevant motivator for PA and therefore 
removal was justified. Intrinsic motivation is behavior motivation driven entirely by the 
joy of the activity. Research suggests that in PA settings, identified regulation is a 
stronger predictor of PA behavior than intrinsic motivation (Teixeira et al., 2012). An 
examination of the open-ended responses suggested that participants were not 
participating in PA for the enjoyment of the activity, but instead were driven primarily by 
the ability to control the disease (identified regulation). The benefits derived from the 
activity specifically, previous research, the high path loading of identified regulation, and 
the open-ended responses suggest motives for PA that were not inherently intrinsic, 
therefore removing intrinsic motivation from the model was justified. The final model is 
a logically sound and statistically significant representation of the research question, 
demonstrating self-efficacy and identified regulation predict PA.  
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The second research question focused on the relationship between PA 
participation and quality of life. Based on previous research, the expectation was that 
individuals with MS who are more physically active would have higher perceived quality 
of life. First this relationship was explored with overall life satisfaction and results of 
regression analysis supported the positive relationship between PA and overall quality of 
life. The second part of the research question involved PA as a predictor of the individual 
subscales of the QoL measure (social, spiritual, emotional, cognitive, physical, and 
ADL). Attempts to model these relationships were unsuccessful, most likely due to high 
multicollinearity, and previous findings suggest that the individual subscales were 
predictors of the QoL Integrated scale (Gill et al., 2015). In the current study the resulting 
model of this relationship indicated that all but cognitive QoL predicted integrated QoL, 
suggesting that cognitive quality of life may be seen as a separate construct by this 
population. Cognitive problems are one of the few MS symptoms that are not physical in 
nature and are reported by a large percentage of individuals with MS (Motl, Snook, 
McAuley, & Gliottoni, 2006; “Symptoms & Diagnosis,” n.d.).   
 Open-ended responses supported PA enhancing all aspects of quality of life and 
MS negatively impacting it. A majority of participants reported excellent or good quality 
of life, with 70% of responses in these two categories. However, when asked specifically 
about the impact of MS on quality of life, only 15% of respondents reported that MS did 
not have any impact on quality of life. The remaining respondents indicated various ways 
that MS negatively impacted their lives including limiting physical ability and causing 
fatigue, limiting cognitive functioning, causing emotional strain, and increasing 
 
 
 
82 
 
depression, limiting employment status and social ability, and generally decreasing all 
aspects of quality of life.  This is in line with previous research showing a negative 
impact on quality of life as a result of MS symptoms (Motl & McAuley, 2010). 
Participants discussed benefits of PA participation that suggested increased overall 
quality of life, even when not being directly asked about the relationship of PA to quality 
of life. Participants also cited benefits of PA that aligned with the QoL subscales, and 
many participants cited more than one type of increase in quality of life that resulted from 
PA. For instance, one participant wrote (in response to the question about what motivates 
her to be physically active): “The fellowship [social quality of life].  The feeling of pride 
I get about myself [emotional quality of life].  The wonderful feeling of using and 
stretching my muscles, and hopefully weight loss [physical quality of life]!!” These 
results parallel the multicollinearity in the individual subscales, and lends strength to the 
decision to use the single integrated QoL scale for the final model.  
 Once both halves of the model were examined, they were combined to model the 
overall relationships among self-efficacy, self-determined motivation, PA, and quality of 
life. This model indicated that a greater portion of PA participation was explained by 
adding identified regulation as well as self-efficacy to the relationship, and PA in turn 
predicted overall quality of life. The model also demonstrated that self-efficacy has a 
direct effect on quality of life, meaning that individuals who feel self-efficacious perceive 
higher overall quality of life, regardless of PA participation.  
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 With the overall model complete, the third research question was examined. It 
was expected that in line with previous findings, the more disabled the individual was, 
the less likely they were to participate in PA (Klaren et al., 2013). In order to explore the 
question of model equivalence, individuals were first divided into low-disease step and 
high disease step. Previous research has shown that walking mobility was the single 
biggest determinant of whether an individual participates in PA (Kahraman, Savci, 
Coskuner-Poyraz, Ozakbas, & Idiman, 2015), and the sample was divided at step 4, the 
point where individuals require walking assistance for mobility.  As expected, results of 
an ANOVA confirmed that individuals in the high disease step group were less likely to 
participate in PA than those in the low disease step group.  
The exploratory analysis to determine if the overall model held constant across 
disability levels indicated the models were equivalent. The path models for individual 
disease step groups were each the same as the overall model, demonstrating that disease 
step does not impact the relationships. This supports the use of the model across all MS 
patients. No differences between models were expected, and the result suggests the 
current findings and model might apply to the entire spectrum of the MS population. This 
also suggests that PA can be just as important to the more disabled portion of the MS 
population for increasing quality of life. These results suggest that future interventions 
should focus on the entire range of disability for the biggest impact.  
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Implications 
 This research was the first of its kind to use SDT in conjunction with self-efficacy 
to predict PA behavior, and also examine overall quality of life using a path model with 
the MS population. Results indicated that the combination of self-determined motivation 
(identified regulation) along with self-efficacy was a stronger predictor of PA behavior 
than using self-efficacy by itself, as has been done previously (for examples see: Jongen 
et al., 2014; Motl, McAuley, Wynn, Sandroff, & Suh, 2013; Motl & Snook, 2008). In 
light of the extremely high level of inactivity in the MS population the current findings 
add another piece to the puzzle of PA motivation for this population, and that information 
may help develop effective interventions.  
This research also adds to the growing understanding surrounding the role PA has 
in impacting quality of life in individuals with MS. Previous research has established the 
quality of life benefits seen by MS patients with PA participation (Motl & McAuley, 
2010; Motl et al., 2013). This project confirmed these findings. Additionally, the open-
ended responses provide greater insight into the complex relationships among PA, MS, 
and quality of life. Participants reported the desire and/or ability to incorporate PA into 
their lives because of the potential physical benefits (which resulted in quality of life 
benefits), but at the same time many reported short-term negative outcomes. Pain and 
fatigue were cited as direct results of PA for many of the participants. The dichotomy of 
positive and negative outcomes is important in understanding the current physical 
inactivity levels of MS patients. PA is beneficial to long-term quality of life, but there are 
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short-term negative outcomes that are sometimes experienced, discouraging PA.  This 
needs to be considered as interventions are developed. Promoting the positive long-term 
quality of life outcomes of PA without acknowledging the possible short-term negative 
impact only provides part of the picture. Adherence to a PA program is increased through 
education of participants (Ransdell, 2009). Educating individuals with MS about the 
long-term positive outcomes (increased quality of life), in spite of the possible short-term 
negative outcomes, may be an effective means to increasing PA participation thus 
increasing quality of life. 
The goal of this project was to develop an overall model to explain the 
relationships among self-efficacy, self-determined motivation, PA, and quality of life. 
The information that the model provides becomes relevant to real-world problems only 
when it is translated into practice. The next logical step is to develop an intervention 
using the roadmap that the model provides to develop a PA program for individuals with 
MS. Based on the results of this project, the program should focus on increasing self-
efficacy and identified regulation in participants in a PA context. Longitudinal studies on 
self-efficacy and PA in MS patients suggest that the individual’s belief that they can 
continue PA participation long-term is the biggest predictor of self-efficacy for PA 
participation (Motl, McAuley, Doerksen, Hu, & Morris, 2009). This would suggest that 
interventions should be designed to specifically increase self-efficacy for long-term PA. 
This could be done through a longitudinal program designed to teach PA behaviors 
throughout the duration of the program. For example, this could be a program designed to 
 
 
 
86 
 
teach MS patients how to effectively exercise within their limitations. Upon program 
completion, they would have the skills and knowledge to be confident in future PA. 
Previous PA research has not used SDT with the MS population however, in 
accordance to the model, identified regulation is also a predictor of PA and therefore 
should be included in future interventions. Identified regulation is motivation from the 
benefits the activity provides the individual. For the MS population, these benefits come 
in the form of physical symptom control. This was echoed repeatedly in the open-ended 
responses, PA was a means to an end – controlling MS. Due to the nature of MS, the 
physical benefits gained through PA are much more drastic and immediate compared to 
the general population (Motl & Sandroff, 2015). Participants reported PA making a 
difference in daily functioning; it can be the difference between being able to care for 
one’s self or needing assistance. Using the same hypothetical program mentioned above, 
identified regulation could be incorporated through tracking changes in physical ability 
both in the program and in day-to-day life. Logging PA improvements and how those 
improvements translate into real world functioning is the key to effectively incorporating 
SDT and specifically identified regulation into an intervention.  
PA increases physical ability and this translates into physical quality of life 
outcomes that impact overall quality of life. Therefore, a program based on the model 
focusing on developing self-efficacy through guided participation and identified 
regulation through education should result in developing long term PA participation. This 
in turn should increase overall quality of life.  
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Limitations and Other Considerations 
As with all research, this study has limitations. It should be noted that these path 
analyses are an attempt to fit a model to data, good fit does not guarantee the model is 
substantively correct (Kline, 2011). An examination of integrated quality of life in the 
final model shows that 90% of the variance in quality of life is still not accounted for. 
This suggests that other variables that are not included in the model influence overall 
quality of life. It is important to note that quality of life is a multidimensional and 
complex construct that may not be easily measured with survey research (Gill et al., 
2013). Without taking participants’ individual needs and situations into consideration, it 
is extremely difficult to assess the impact that PA has on quality of life (Gill et al., 2013). 
This is the most probable reason for the high variance in the model.  
It is important to consider that in path analysis, the direction of each path is 
specified as unidirectional. In real-world situations, this is not necessarily true. For 
example, there is research that supports a two-way relationship between self-efficacy and 
PA participation – the higher the person is on self-efficacy the more likely they are to 
participate (as the model indicates), but also the more they participate in PA the higher 
their self-efficacy for PA is (Bandura, 1997). It is possible that many of the paths fit this 
type of bidirectional theory. If that is the case, then this is less of a predictive model and 
more a picture of one of the many ways these relationships may occur at a given point.   
Self-determination as posited by SDT, is an artificially divided trait (amotivation, 
external regulation, introjected regulation, identified regulation, integrated regulation, and 
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intrinsic motivation). The motivational continuum is divided into categories and 
behavioral traits are assigned to those categories. There is no room for individuals to 
possess characteristics that do not fit a single category. It may make more sense to have 
each of the levels of the continuum act like dimmer switches – where the individual 
possesses all of the categories and the situation dictates which categories are on “high” 
and which are not. If this is the case, then modeling the relationship as the present project 
has done is simplistic and limiting. With a multidimensional trait model such as this it 
would be more appropriate to do cluster type analysis.  
It is also possible that the sample of individuals who responded were biased 
toward PA behavior. Although the recruitment flyer, email, and posted information were 
general in their description of the research, the stated purpose of the study (to examine 
PA participation and quality of life perceptions) was disclosed in IRB informed consent 
form and the information could have contributed to the large number of individuals (n = 
50) who stopped participating after initially clicking on the link and reading the informed 
consent. Additionally, even the general recruitment flyer stated the research was about 
“quality of life and recreational activities” and this may have been enough to turn off 
many participants. If those 50 individuals had drastically differing views than the sample 
respondents the results may be different. There is also speculation that participants who 
volunteer for research are inherently different than the portion of the population that does 
not respond (Abraham, Helms, & Presser, 2009; “Assessing the Representativeness of 
Public Opinion Surveys,” 2012; Smith, 2012). Nonresponse rate becomes especially 
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relevant when the same type of characteristics that may increase the likelihood of survey 
response, such as motivation, are being examined in the research.  
Recruitment for this project primarily used the NMSS, regional NMSS chapters, 
and local support groups. Individuals with MS who are not involved in this type of peer 
support were not reached. It is possible that certain characteristics inherent to those 
individuals who are members of these types of groups are the same characteristics seen in 
the results. For example, depression is a well-known and often reported symptom of MS 
(Coyle & Hamaad, 2006). Depression is also known to limit social interactions and cause 
individuals to become withdrawn and isolated, which then would suggest a lower 
likelihood of participation in groups, social interactions, and general contact with the rest 
of the world (Johnson, 2000). Depression is only one example of the many confounds 
that may limit an individual’s participation in this research because of recruitment.  
Conclusion 
 MS affects the lives of 2.1 million people worldwide (National Multiple Sclerosis 
Society, 2005). The neurological damage that occurs during disease progression can take 
many forms and may impact multiple aspects of the individual’s physical and cognitive 
functioning ability. Disease management relies on effectively managing symptoms 
through various methods, including PA, in an effort to improve long-term prognosis, 
resulting in increased quality of life. PA benefits for individuals with MS are well 
documented and the evidence continues to grow (Motl & McAuley, 2009; Motl & Snook, 
2008). In spite of this information, the MS population is largely inactive (Klaren et al., 
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2013). This project was designed to examine SDT in conjunction with self-efficacy in an 
examination of PA. The goal of project was to understand how to increase PA 
participation to improve quality of life by developing a model of the relationships among 
self-efficacy, self-determined motivation, PA, and quality of life. This model added new 
information to the existing body of research surrounding PA motivation in MS patients 
by introducing identified regulation as a motivator for PA. The model demonstrated self-
efficacy and identified regulation were predictors of PA and PA was a predictor of 
quality of life. Results were confirmed in the open-ended responses, with self-efficacy 
and self-determined motivation described as reasons individuals are physically active, 
and PA was cited as a means to directly and indirectly increase quality of life. These 
results provide promising directions for the future of PA interventions in the MS 
population. This model can guide future interventions to effectively promote PA in the 
MS population, resulting in a more physically active population, and contribute to long-
term disease management and increased quality of life. 
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APPENDIX A  
MEASURES 
 
 
Godin Leisure Time Exercise Questionnaire (Godin) 
 
In this section, we would like to ask you about your current physical activity and exercise 
habits that you perform regularly, at least once a week. Please answer as accurately as 
possible.  
1.) During a typical 7-Day period (a week), how many times on the average do 
you do the following kinds of exercise for more than 15 minutes during your 
free time (write in each box the appropriate number).  
Times/week           
Minutes/session 
 
STRENUOUS EXERCISE (HEART BEATS RAPIDLY):     ____  ____ 
e.g.- running, jogging, elliptical, hockey, football, soccer,  
racquetball, basketball, cross country skiing, martial arts,  
roller skating, vigorous swimming, vigorous long  
distance bicycling 
 
MODERATE EXERCISE (NOT EXHAUSTING):        ____  ____ 
e.g.- fast walking, baseball/softball, badminton, tennis,  
volleyball, easy swimming, easy bicycling, dancing 
 
MILD EXERCISE(MINIMAL EFFORT):       ____  ____ 
e.g.-yoga, archery, fishing, bowling, golf,  
easy walking 
 
 
2.)  Please list specific physical activities that you participate in regularly. 
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Quality of Life Survey – Version 2 (QoL) 
This questionnaire asks how you feel about your quality of life, including your physical, 
emotional, social, spiritual and mental health and well-being.  Please answer all 
questions.  There are no right or wrong answers. Use the 1-5 scale below and circle the 
one number that best describes how you feel about your quality of life.   
 
Poor  Below Average Average    Above Average Excellent 
1            2       3                4       5 
 
How would you rate the quality of your… 
 Poor Below 
Average 
Average Above 
Average 
Excellent 
1. Physical health and well-being 1 2 3 4 5 
2. Personal Relationships 1 2 3 4 5 
3. Peace of mind 1 2 3 4 5 
4. Feeling of happiness 1 2 3 4 5 
5. Ability to concentrate 1 2 3 4 5 
6. Physical fitness 1 2 3 4 5 
7. Overall quality of life 1 2 3 4 5 
8. Ability to think 1 2 3 4 5 
9. Enjoyment of life 1 2 3 4 5 
10. Sense of calm and 
peacefulness 
1 2 3 4 5 
11. Ability to take care of 
yourself 
1 2 3 4 5 
12. Life in general 1 2 3 4 5 
13. Intimate relationships 1 2 3 4 5 
14. Prayer, meditation, or 
individual spiritual study 
1 2 3 4 5 
15. Ability to do activities of 
daily living 
1 2 3 4 5 
16. Happiness in general 1 2 3 4 5 
17. Ability to initiate and 
maintain relationships 
1 2 3 4 5 
How would you rate the quality of your… 
 Poor Below 
Average 
Average Above 
Average 
Excellent 
18. Spiritual growth 1 2 3 4 5 
19. Sense of NOT feeling sad, 
blue, or depressed 
1 2 3 4 5 
20. Ability to solve problems 1 2 3 4 5 
21. Emotional relationships with 
others 
1 2 3 4 5 
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22. Spiritual beliefs 1 2 3 4 5 
23. Sense of NOT feeling 
worried, tense or anxious 
1 2 3 4 5 
24. Body shape 1 2 3 4 5 
25. Spiritual life 1 2 3 4 5 
26. Memory 1 2 3 4 5 
27. Bodily appearance 1 2 3 4 5 
28. Social relationships 1 2 3 4 5 
29. Faith 1 2 3 4 5 
30. Ability to continue learning 1 2 3 4 5 
31. Level of Physical activity 1 2 3 4 5 
32. Ability to get around 1 2 3 4 5 
 
 
QoL Survey Scales and Related Items: 
Social (5 items): Q2 + Q13 + Q17 + Q21 + Q28 
Spiritual (5 items):  Q14 + Q18 + Q22 + Q25 + Q29 
Emotional (5 items):  Q3 + Q4 + Q10 + Q19 + Q23 
Cognitive (5 items):  Q5 + Q8 + Q20 + Q26 + Q30 
Physical (5 items):  Q1 + Q6 + Q24 + Q27 + Q31 
ADL/functional (3 items):  Q11 + Q15 + Q32 
Integrated (4 items):  Q7 + Q9 + Q12 + Q16
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Satisfaction with Life Scale (SWLS) 
 
Below are five statements that you may agree or disagree with. Using the 1 - 7 scale 
below, indicate your agreement with each item by placing the appropriate number on the 
line preceding that item. Please be open and honest in your responding. 
 
 7 - Strongly agree  
 6 - Agree  
 5 - Slightly agree  
 4 - Neither agree nor disagree  
 3 - Slightly disagree  
 2 - Disagree  
 1 - Strongly disagree 
____ In most ways my life is close to my ideal.  
____ The conditions of my life are excellent. 
____ I am satisfied with my life. 
____ So far I have gotten the important things I want in life. 
____ If I could live my life over, I would change almost nothing. 
 31 - 35 Extremely satisfied  
 26 - 30 Satisfied  
 21 - 25 Slightly satisfied  
 20        Neutral  
 15 - 19 Slightly dissatisfied  
 10 - 14 Dissatisfied  
  5 -  9   Extremely dissatisfied  
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The Self-Determination Scale (SDS) 
 
Instructions: Please read the pairs of statements, one pair at a time, and think about 
which statement within the pair seems more true to you at this point in your life.  
Indicate the degree to which statement A feels true, relative to the degree that Statement 
B feels true, on the 5-point scale shown after each pair of statements. If statement A 
feels completely true and statement B feels completely untrue, the appropriate response 
would be 1. If the two statements are equally true, the appropriate response would be a 3.  
If only statement B feels true 
And so on. 
 
1.  
 A.  I always feel like I choose the things I do. 
B.  I sometimes feel that it’s not really me choosing the things I do. 
 
Only A feels true 1 2 3 4 5 Only B feels true 
 
2.  
 A.  My emotions sometimes seem alien to me. 
B.  My emotions always seem to belong to me. 
 
Only A feels true 1 2 3 4 5 Only B feels true 
 
3. 
 A.  I choose to do what I have to do. 
B.  I do what I have to, but I donÕt feel like it is really my choice. 
 
Only A feels true 1 2 3 4 5 Only B feels true 
 
4. 
 A.  I feel that I am rarely myself. 
B.  I feel like I am always completely myself. 
 
Only A feels true 1 2 3 4 5 Only B feels true 
 
5.  
 A.  I do what I do because it interests me. 
B.  I do what I do because I have to. 
 
Only A feels true 1 2 3 4 5 Only B feels true 
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6. 
 A.  When I accomplish something, I often feel it wasn't really me who did it. 
B.  When I accomplish something, I always feel it's me who did it. 
 
Only A feels true 1 2 3 4 5 Only B feels true 
 
7. 
 A.  I am free to do whatever I decide to do. 
B.  What I do is often not what I'd choose to do. 
 
Only A feels true 1 2 3 4 5 Only B feels true 
 
8. 
              A.  My body sometimes feels like a stranger to me. 
B.  My body always feels like me. 
 
Only A feels true 1 2 3 4 5 Only B feels true 
 
9. 
 A.  I feel pretty free to do whatever I choose to. 
B.  I often do things that I don't choose to do. 
 
Only A feels true 1 2 3 4 5 Only B feels true 
 
10. 
 A.  Sometimes I look into the mirror and see a stranger. 
B.  When I look into the mirror I see myself. 
 
Only A feels true 1 2 3 4 5 Only B feels true 
 
 
Scoring Information for the SDS. First, items 1, 3, 5, 7, 9 need to be reverse scored so 
that higher scores on every item will indicate a higher level of self-determination. To 
reverse score an item, subtract the item response from 6 and use that as the item score. 
Then, calculate the scores for the Awareness of Self subscale and the Perceived Choice 
subscale by averaging the item scores for the 5 items within each subscale. The 
subscales are: 
 
Awareness of Self:   2, 4, 6, 8, 10 
Perceived Choice: 1, 3, 5, 7, 9 
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EXERCISE REGULATIONS QUESTIONNAIRE (BREQ-2) 
 
WHY DO YOU ENGAGE IN EXERCISE? 
 
We are interested in the reasons underlying peoples’ decisions to engage, or not engage 
in physical exercise. Using the scale below, please indicate to what extent each of the 
following items is true for you. Please note that there are no right or wrong answers and 
no trick questions. We simply want to know how you personally feel about exercise. 
Your responses will be held in confidence and only used for our research purposes. 
 
 
 Not true Sometimes Very 
true 
 for me true for me for me 
 
1 I exercise because other people 0 1 2 3 4 
 say I should 
  
2 I feel guilty when I don’t exercise 0 1 2 3 4 
 
3 I value the benefits of exercise 0 1 2 3 4 
 
4 I exercise because it’s fun 0 1 2 3 4 
 
5 I don’t see why I should have to exercise 0 1 2 3 4 
 
6 I take part in exercise because my 0 1 2 3 4 
 friends/family/partner say I should 
 
7 I feel ashamed when I miss an 0 1 2 3 4 
 exercise session 
 
8 It’s important to me to exercise regularly 0 1 2 3 4 
 
9 I can’t see why I should bother exercising 0 1 2 3 4 
 
10 I enjoy my exercise sessions 0 1 2 3 4 
 
11 I exercise because others will not be 0 1 2 3 4 
 pleased with me if I don’t 
 
12 I don’t see the point in exercising 0 1 2 3 4 
 
13 I feel like a failure when I haven’t 0 1 2 3 4 
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 exercised in a while 
 
14 I think it is important to make the effort to 0 1 2 3 4 
 exercise regularly 
 
15 I find exercise a pleasurable activity 0 1 2 3 4 
 
16 I feel under pressure from my friends/family 0 1 2 3 4 
 to exercise 
 
17 I get restless if I don’t exercise regularly 0 1 2 3 4 
  
18 I get pleasure and satisfaction from 0 1 2 3 4 
 participating in exercise  
 
19 I think exercising is a waste of time 0 1 2 3 4 
 
 
Thank you for taking part in our research 
 
  
 
117 
 
Patient Determined Disease Step (PDDS) 
Please read the choices listed below and choose the one that best describes your own 
situation. This scale focuses mainly on how well you walk. Not everyone will find a 
description that reflects their condition exactly, but please mark the one category that 
describes your situation the closest. 
 
 0 Normal:   I may have some mild symptoms, mostly sensory due to MS but they 
do not limit my activity. If I do have an attack, I return to normal when the attack has 
passed.  
 1 Mild Disability:    I have some noticeable symptoms from my MS but they are 
minor and have only a small effect on my lifestyle. 
 2 Moderate Disability:   I don't have any limitations in my walking ability. 
However,    I do have significant problems due to MS that limit daily activities in other 
ways. 
 3 Gait Disability:    MS does interfere with my activities, especially my walking. I 
can work a full day, but athletic or physically demanding activities are more difficult than 
they used to be. I usually don't need a cane or other assistance to walk, but I might need 
some assistance during an attack. 
 4 Early Cane:    I use a cane or a single crutch or some other form of support (such 
as touching a wall or leaning on someone's arm) for walking all the time or part of the 
time, especially when walking outside. I think I can walk 25 feet in 20 seconds without a 
cane or crutch. I always need some assistance (cane or crutch) if I want to walk as far as 3 
blocks. 
 5 Late Cane:    To be able to walk 25 feet, I have to have a cane, crutch or someone 
to hold onto. I can get around the house or other buildings by holding onto furniture or 
touching the walls for support. I may use a scooter or wheelchair if I want to go greater 
distances.                                                                       
 6 Bilateral Support:   To be able to walk as far as 25 feet I must have 2 canes or 
crutches or a walker. I may use a scooter or wheelchair for longer distances. 
 7 Wheelchair / Scooter:    My main form of mobility is a wheelchair. I may be able 
to stand and/or take one or two steps, but I can't walk 25 feet, even with crutches or a 
walker. 
 8   Bedridden:    Unable to sit in a wheelchair for more than one hour. 
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Exercise Self-Efficacy Scale (EXSE) 
The items listed below are designed to assess your beliefs in your ability to continue 
exercising on a three time per week basis at moderate intensities (upper end of your 
perceived exertion range), for 40+ minutes per session in the future. Using the scales 
listed below please indicate how confident you are that you will be able to continue to 
exercise in the future. 
 
For example, if you have complete confidence that you could exercise three times 
per week at moderate intensity for 40+ minutes for the next four weeks without 
quitting, you would circle 100%. However, if you had no confidence at all that you 
could exercise at your exercise prescription for the next four weeks without quitting, 
(that is, confident you would not exercise), you would circle 0%. 
   
   Please remember to answer honestly and accurately.  There are no right or wrong 
answers. 
 
Mark your answer by circling a %: 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
 100% 
 
NOT AT ALL MODERATELY HIGHLY 
CONFIDENT CONFIDENT CONFIDENT 
 
 
1. I am able to continue to exercise three times per week at moderate 
intensity, for 40+ minutes without quitting for the NEXT WEEK 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
 100% 
 
2. I am able to continue to exercise three times per week at moderate 
intensity, for 40+ minutes without quitting for the NEXT TWO 
WEEKS 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
 100% 
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3. I am able to continue to exercise three times per week at moderate 
intensity, for 40+ minutes without quitting for the NEXT THREE 
WEEKS 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
 100% 
 
4. I am able to continue to exercise three times per week at moderate 
intensity, for 40+ minutes without quitting for the NEXT FOUR 
WEEKS 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
 100% 
  
5. I am able to continue to exercise three times per week at moderate 
intensity, for 40+ minutes without quitting for the NEXT FIVE 
WEEKS 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
 100% 
 
6. I am able to continue to exercise three times per week at moderate 
intensity, for 40+ minutes without quitting for the NEXT SIX 
WEEKS 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
 100% 
 
7. I am able to continue to exercise three times per week at moderate 
intensity, for 40+ minutes without quitting for the NEXT SEVEN 
WEEKS 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
 100% 
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8. I am able to continue to exercise three times per week at moderate 
intensity, for 40+ minutes without quitting for the NEXT EIGHT 
WEEKS 
 
0% 10% 20% 30% 40% 50% 60% 70% 80% 90%
 100% 
 
 
********** 
 
Scoring: Sum all items and divide by 8 
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Markus Self-Efficacy for Physical Activity 
 
Choose the number to indicate how confident you are that you could be physically active 
in each of the following situations 
Scale: 
1 = not at all confident 
2 = slightly confident 
3 = moderately confident 
4 = very confident 
5 = extremely confident 
 
I am confident I can participate in regular exercise when: 
I am tired. 1 2 3 4 5 
I am in a bad mood. 1 2 3 4 5 
I feel I don’t have the time. 1 2 3 4 5 
I am on vacation. 1 2 3 4 5 
It is raining or snowing. 1 2 3 4 5 
 
Scoring: Add all score and divide by 5. Total self-efficacy for PA score ranges from 5 to 
25.  
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Basic Demographics Questions 
 
1. How old are you (in years)? 
2. What gender do you identify with? (male/female) 
3. What race/ethnicity do you identify with? 
a. White 
b. African American 
c. American Indian 
d. Hispanic 
e. Asian/Pacific Islander 
f. Other 
g. Prefer not to answer 
4. What is the highest level of education you have completed? 
a. High school 
b. Some college 
c. College degree 
d. Graduate degree 
e. Other  
5. Are you employed? (yes/no) 
a. If so, what is your current occupation? 
6. How long ago were you diagnosed with MS? (in years) 
7. How often do you experience acute MS flare-ups that impact your daily life? 
a. 1 or less 
b. 2-3 times per year 
c. 4-6 times per year 
d. 6-8 times per year 
e. 9 or more times per year 
8. When was your last MS flare-up? 
a. Less than 1 month ago 
b. 1-2 months ago 
c. 3-4 months ago 
d. 5-6 months ago 
e. 7-9 months ago 
f. 10-12 months ago 
g. More than 12 months ago 
9. What are the most common MS symptoms that you experience?  
10. Are you physically active? (yes/no) 
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11. Were you physically active before you were diagnosed with MS? (yes/no) 
12. What types of physical activity do you participate in? 
 
Open-ended Questions 
1. What are the most common MS symptoms you experience? 
2. What type of recreational activities do you participate in/enjoy? 
3. Describe your overall quality of life. 
4.  How does MS impact your quality of life? 
5. What motivates you to be physically active (if you are)? 
6. How does PA make you feel?  
7. How does PA specifically relate to your MS? 
8. How does PA impact your overall quality of life? 
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APPENDIX B  
RECRUITMENT MATERIALS 
 
 
Email recruiting script 
Hello. 
 
My name is Kimberly Fasczewski and I am a doctoral candidate in the Kinesiology 
department at The University of NC at Greensboro. My specific research interests 
explore quality of life in individuals with multiple sclerosis (MS). My dissertation 
research examines some of the factors that may impact quality of life in people with MS 
such as recreational activities and physical activity participation.  
 
Participants for this research need to be between the ages of 18 and 65 and have been 
diagnosed with MS at least one year ago. There are no other requirements.  
 
As a participant, you will be asked to fill out an anonymous online survey that will take 
less than 20 minutes of your time and can be done at your convenience. The survey will 
ask about your thoughts, behaviors, and motives for activities you may participate in as 
well as how you rate your quality of life and satisfaction with life. If at any time during 
the online survey you no longer wish to participate you are welcome to stop. You have no 
obligation to continue. The results you have already submitted at that point may still be 
used.  
 
There is no compensation for participation but this research is designed to help advance 
knowledge and treatment protocols for MS. Your participation can help that.  
 
Thank you for your time. Please feel free to contact myself or my advisor if you have any 
questions or concerns. 
 
Survey link: https://uncg.qualtrics.com.SE/?SID=SV_3JH5TjvAH6TCLPf   
 
Kimberly Fasczewski 
Doctoral Candidate, Sport and Exercise Psychology, UNCG 
ksfascze@uncg.edu  
 
Faculty Advisor 
Diane Gill, PhD 
dlgill@uncg.edu  
Department of Kinesiology, The University of North Carolina at Greensboro 
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Online Recruitment Flyer 
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APPENDIX C  
ADDITIONAL TABLES 
 
 
 Table 26. Correlations for All Measures 
* significant at p < .05; ** significant at p < .01 
  1 2 3 4 
 
5 6 7 8 9 10 11 12 13 14 15 16 
1 EXSE 1                
2 MSES .58** 1               
3 SDS .27** .32** 1              
4 Amotivation -.38** -.46** -.37** 1             
5 External -.16* -.19** -.21** .33** 1            
6 Introjected .13 .12 -.13 -.18** .28** 1           
7 Identified .55** .56** .24** -.62** -.16* .45** 1          
8 Intrinsic .29** .37** .59** -.26** -.03 -.11 .18* 1         
9 PA Level .48** .43** .21** -.28** -.19** .12 .40** .24** 1        
10 Social QoL .28** .38** .57** -.35** -.10 .01 .29** .76** .22** 1       
11 Spiritual QoL .04 .19** .34** -.16** .04 -.09 .10 .68** .04 .50** 1      
12 Emotional QoL .24* .32** .59** -.23** -.10 -.19** .13 .90** .20** .75** .53** 1     
13 Cognitive QoL .28** .39** .45** -.25** -.02 .01 .36** .55** .22** .53** .34** .54** 1    
14 Physical QoL .57** .58** .45** -.39** -.12 .07 .46** .59** .47** .53** .25** .50** .49** 1   
15 ADL QoL .40** .48** .46** -.28** -.08 .02 .21** .69** .35** .51** .26** .49** .43** .69** 1  
16 Integrated QoL .29** .37** .65** -.34** -.14* -.11 .19** .87** .26** .80** .44** .88** .56** .63** .65** 1 
17 SWLS .36** .42** .59** -.30** -.15 -.06 .23** .74** .31** .72** .38** .72** .48** .61** .64** .81** 
1
2
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